{"content":"<li class=\"n-box-item date-title\" data-end=\"1549342799\" data-start=\"1549256400\" data-txt=\"Monday, December 23, 2019\">Monday, February  4, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3429376\" data-ts=\"1549336815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKTS\" target=\"_blank\">AKTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429376-akoustis-technologies-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akoustis Technologies EPS in-line, misses on revenue</a></h4><ul><li>Akoustis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTS' title='Akoustis Technologies, Inc.'>AKTS</a>): Q2 GAAP EPS of -$0.24 in-line.</li><li>Revenue of $0.32M (-27.3% Y/Y) <font color=\"red\">misses by $0.09M</font>.</li><li>Shares <font color=\"green\">+10%</font> AH.</li><li><a href=\"https://seekingalpha.com/filing/4326780\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3429376\" data-linked=\"Akoustis Technologies EPS in-line, misses on revenue\" data-tweet=\"$AKTS - Akoustis Technologies EPS in-line, misses on revenue https://seekingalpha.com/news/3429376-akoustis-technologies-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3429376-akoustis-technologies-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429356\" data-ts=\"1549319779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STX\" target=\"_blank\">STX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429356-tech-dominate-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech dominate after hours movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color=\"green\">+3.1%</font>. <a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a> <font color=\"green\">+2.7%</font>. <a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a> <font color=\"green\">+1.7%</font>. <a href='https://seekingalpha.com/symbol/KSHB' title='KushCo Holdings, Inc.'>OTCQB:KSHB</a> <font color=\"green\">+1.3%</font>. <a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a> <font color=\"green\">+1.3%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color=\"red\">-19.9%.</font> <a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a> <font color=\"red\">-13.9%</font>. <a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a> <font color=\"red\">-9.1%</font>. <a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a> <font color=\"red\">-8.1%</font>. <a href='https://seekingalpha.com/symbol/AEIS' title='Advanced Energy Industries, Inc.'>AEIS</a> <font color=\"red\">-6.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429356\" data-linked=\"Tech dominate after hours movers\" data-tweet=\"$STX $STX $APHA - Tech dominate after hours movers https://seekingalpha.com/news/3429356-tech-dominate-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3429356-tech-dominate-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429349\" data-ts=\"1549319119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BZH\" target=\"_blank\">BZH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429349-beazer-homesminus-3_3-amid-disappointing-q1-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beazer Homes -3.3% amid disappointing Q1 revenue</a></h4><ul><li>Beazer Homes (NYSE:<a href='https://seekingalpha.com/symbol/BZH' title='Beazer Homes USA, Inc.'>BZH</a>)<font color=\"red\"> falls 3.3%</font> in after-hours trading after <a href=\"https://seekingalpha.com/pr/17400966-beazer-homes-reports-first-quarter-fiscal-2019-results\" target=\"_blank\">fiscal Q1 revenue</a> for $402.0M misses consensus estimate by $4.6M and the quarter's cancellation rate of 19.8% increased from 18.9% a year earlier.</li><li>Q1 homebuilding gross margin was 15.1%, down 130 basis points; excluding impairments, abandonments, and amortized interest, homebuilding gross margin was 19.7%, down 120 bps.</li><li>Q1 EPS of 23 cents exceeds average analyst estimate of 14 cents.</li><li>Q1 adjusted EBITDA of $26.8M, down 5.5%.</li><li>Dollar value of backlog of $593.1M, down  16%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429296-beazer-homes-beats-0_08-misses-revenue\" target=\"_blank\">Beazer Homes beats by $0.08, misses on revenue</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429349\" data-linked=\"Beazer Homes -3.3% amid disappointing Q1 revenue\" data-tweet=\"$BZH - Beazer Homes -3.3% amid disappointing Q1 revenue https://seekingalpha.com/news/3429349-beazer-homesminus-3_3-amid-disappointing-q1-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3429349-beazer-homesminus-3_3-amid-disappointing-q1-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429341\" data-ts=\"1549317971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429341-roku-pares-heavy-gains-comcast-disputes-bestappletv-story\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku pares heavy gains as Comcast disputes BestAppleTV story</a></h4><ul>   <li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) gave up much of its <a href=\"https://seekingalpha.com/news/3429183-roku-marks-double-digit-gain-amid-executive-change-comcast-streaming-report\" target=\"_blank\">double-digit gains for the day</a> in the closing minutes, as Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) acted to knock down a story credited with Roku's boost.</li>    <li>Roku closed <font color=\"green\">up 4.9%</font> after <font color=\"green\">rising as much as 12.1%</font> today after a BestAppleTV report that Comcast had decided against building a stand-alone tvOS app to stream its cable systems, instead seemingly preferring to rely on a Sky solution that uses Roku infrastructure.</li>    <li>A short bit ago, Comcast <a href=\"https://corporate.comcast.com/press/releases/comcast-statement-on-xfinity-tv-and-streaming-devices\" target=\"_blank\">released a statement</a> citing \"numerous inaccuracies\" in BestAppleTV's report.</li>    <li>That story \"wrongly conflates individual business dealings and relationships from Sky, NBCUniversal and Comcast Cable.\"</li>    <li>Comcast is \"deeply invested\" in develping its Xfinity X1 platform, and while more than two-thirds of Xfinity TV customers have X1, \"we also provide our customers choice and flexibility in accessing their video subscription on their owned devices.\"</li>    <li>And customers can access their subscription \"via the Xfinity Stream app on iOS and Android mobile devices, and on computers and laptops via the Xfinity Stream web portal. Customers can also access their subscription on the TV via the Xfinity Stream app for Roku devices and Samsung smart TVs (and soon LG and Sony smart TVs as well), or use their Xfinity credentials to authenticate more than 130 networks across more than 20 devices including Apple TV, Roku, Amazon Fire TV, Google Chromecast, and Xbox One, among others, or via CableCARD devices like TiVo.\"</li><li>Comcast says it's actively in talks with other device manufacturers to distribute Xfinity Stream.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429341\" data-linked=\"Roku pares heavy gains as Comcast disputes BestAppleTV story\" data-tweet=\"$ROKU $CMCSA - Roku pares heavy gains as Comcast disputes BestAppleTV story https://seekingalpha.com/news/3429341-roku-pares-heavy-gains-comcast-disputes-bestappletv-story?source=tweet\" data-url=\"https://seekingalpha.com/news/3429341-roku-pares-heavy-gains-comcast-disputes-bestappletv-story\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429334\" data-ts=\"1549317561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTNA\" target=\"_blank\">QTNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429334-quantennaminus-4_2-amid-light-guidance-for-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quantenna -4.2% amid light guidance for Q1</a></h4><ul>   <li>Quantenna Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNA' title='Quantenna Communications'>QTNA</a>) is <font color=\"red\">4.2% lower</font> after hours following a Q4 report where revenue jumped more than 50% but revenue guidance came in on the light side for the current quarter.</li>    <li>Gross profit rose 47% to $31.3M; gross margin dropped 160 basis points to 50%.</li>    <li>And while GAAP net income fell to $1.42M from $32.3M, non-GAAP net income jumped to $7.6M from $455,000. Heavy disparities in stock-based compensation and income taxes accounted for much of the difference.</li>    <li>For Q1, it's guiding to revenue of $56M-$59M (vs. consensus for $59.5M), non-GAAP gross margin of 50.5% plus or minus 50 bps, and EPS of $0.13-$0.15 (in line with consensus for $0.14%).</li>    <li><a href=\"https://seekingalpha.com/article/4237967-quantenna-communications-2018-q4-results-earnings-call-slides\" target=\"_blank\">Earnings call slides</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3429281-quantenna-communications-eps-line-beats-revenue\" target=\"_blank\">Quantenna Communications EPS in-line, beats on revenue</a> (Feb. 04 2019)</li>   <li><a href=\"https://seekingalpha.com/pr/17400917-quantenna-announces-fourth-quarter-fiscal-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3429334\" data-linked=\"Quantenna -4.2% amid light guidance for Q1\" data-tweet=\"$QTNA - Quantenna -4.2% amid light guidance for Q1 https://seekingalpha.com/news/3429334-quantennaminus-4_2-amid-light-guidance-for-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3429334-quantennaminus-4_2-amid-light-guidance-for-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429331\" data-ts=\"1549317322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTI\" target=\"_blank\">ULTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429331-ultimate-software-reports-q4-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultimate Software reports Q4 beats</a></h4><ul><li>Ultimate Software (NASDAQ:<a href='https://seekingalpha.com/symbol/ULTI' title='Ultimate Software Group, Inc. &#40;The&#41;'>ULTI</a>) reports Q4 beats with revenue up 21% Y/Y. This morning, ULTI <a href=\"https://seekingalpha.com/news/3428952-ultimate-software-agrees-11b-acquisition\" target=\"_blank\">announced</a> it will be acquired by PE firm Hellman &amp; Friedman for about $11B in an all-cash transaction.</li><li>Revenue breakdown: Recurring, $266.4M (consensus: $263.4M); Services, $38.4M (consensus: $37.2M).</li><li>ULTI isn't hosting an earnings call or providing guidance because of the acquisition.</li><li>ULTI is <font color=\"red\">down 16.5%</font> after closing today <font color=\"green\">up 19.7%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17400884-ultimate-reports-full-year-q4-2018-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429273-ultimate-software-group-beats-0_51-beats-revenue\" target=\"_blank\">Ultimate Software Group beats by $0.51, beats on revenue</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429331\" data-linked=\"Ultimate Software reports Q4 beats\" data-tweet=\"$ULTI - Ultimate Software reports Q4 beats https://seekingalpha.com/news/3429331-ultimate-software-reports-q4-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3429331-ultimate-software-reports-q4-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429329\" data-ts=\"1549316725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRL\" target=\"_blank\">CTRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429329-control4minus-8-on-mixed-q4-downside-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Control4 -8% on mixed Q4, downside guide</a></h4><ul><li>Control4 (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a>)<font color=\"red\"> plunges 8.2%</font> on Q4 results that beat on EPS but missed on revenue despite a 7% Y/Y revenue growth. Downside Q1 guidance has revenue from $61M to $63M (consensus: $63.93M) and EPS from $0.08 to $0.11 (consensus: $0.21).</li><li>FY19 guidance has in-line revenue of $295M to $301M (consensus: $300.45M) with downside EPS from $1.18 to $1.25 (consensus: $1.53).</li><li>Acquisition: Control4 <a href=\"https://seekingalpha.com/pr/17400954-control4-acquires-switzerland-based-neeo\" target=\"_blank\">announces acquiring </a>smart home remote company NEEO for undisclosed terms.</li><li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Finvestor.control4.com%2F&amp;esheet=51935475&amp;newsitemid=20190204005693&amp;lan=en-US&amp;anchor=http%3A%2F%2Finvestor.control4.com%2F&amp;index=1&amp;md5=5277ca38f3cff62bdfc7668b17414aa4\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17400911-control4-reports-record-revenue-net-income-fiscal-year-2018\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429274-control4-beats-0_01-misses-revenue\" target=\"_blank\">Control4 beats by $0.01, misses on revenue</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429329\" data-linked=\"Control4 -8% on mixed Q4, downside guide\" data-tweet=\"$CTRL - Control4 -8% on mixed Q4, downside guide https://seekingalpha.com/news/3429329-control4minus-8-on-mixed-q4-downside-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3429329-control4minus-8-on-mixed-q4-downside-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429325\" data-ts=\"1549316642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLIT\" target=\"_blank\">HLIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429325-harmonicminus-13-guidance-comes-up-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmonic -13% as guidance comes up short</a></h4><ul>   <li>Harmonic (NASDAQ:<a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a>) has <font color=\"red\">fallen 13%</font> in late trading after its Q4 results, where it beat EPS expectations but provided light guidance for the current quarter's revenues.</li>    <li>Strong growth in Cable Access revenues added to steady progress in its core Video segment. And gross margin rose to 54.5% from 50.1%.</li>    <li>Non-GAAP operating income rose to $12.7M from $1.6M; net income jumped to $0.11/share from break-even a year ago.</li>    <li>CableOS deployments rose 11% sequentially to pass 535,000 served modems, and more than 37,000 OTT channels have been deployed globally.</li>    <li>Revenue breakout: Video, $89.5M (up 2%); Cable Access, $24.1M (up 79%).</li>    <li>For Q1, it's guiding to revenue of $80M-$90M (below consensus for $100.2M). Of that, $70M-$75M is from Video and $10M-$15M from Cable Access. It sees gross margin at 52.5-54.5%, and EPS of -$0.11 to -$0.01 (trailing estimates for $0.05).</li>    <li>For the full year, it's guiding to revenue of $390M-$440M (below consensus for $450.1M). Of that, $290M-$310M is from Video and $100M-$130M from Cable Access. It also sees gross margin of 50-53.5%, and EPS of -$0.16 to $0.33 (vs. expectations for $0.23).</li>    <li><a href=\"https://edge.media-server.com/m6/p/r8h27y8a\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429278-harmonic-beats-0_06\" target=\"_blank\">Harmonic beats by $0.06</a> (Feb. 04 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17400922-harmonic-announces-fourth-quarter-fiscal-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3429325\" data-linked=\"Harmonic -13% as guidance comes up short\" data-tweet=\"$HLIT - Harmonic -13% as guidance comes up short https://seekingalpha.com/news/3429325-harmonicminus-13-guidance-comes-up-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3429325-harmonicminus-13-guidance-comes-up-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429321\" data-ts=\"1549316281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMNX\" target=\"_blank\">LMNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429321-luminex-q4-non-gaap-earnings-down-81-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Luminex Q4 non-GAAP earnings down 81%; shares down 5% after hours</a></h4><ul><li>Luminex (NASDAQ:<a href='https://seekingalpha.com/symbol/LMNX' title='Luminex Corporation'>LMNX</a>) <a href=\"https://seekingalpha.com/pr/17400992-luminex-corporation-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4 results</a> ($M): Total revenues: 81.1 (+3.7%); Assays: 37.0 (-11.5%); Consumables: 15.7 (+57.0%).</li><li>Net income: (2.3) (+22.6%); non-GAAP net income: 1.7 (-80.5%); EPS: (0.05) (+28.6%); non-GAAP EPS: 0.04 (-80.0%); cash flow ops: 4.3 (-81.4%).</li><li>268 multiplexing analyzers shipped.</li><li>Shares are down <font color=\"red\">5%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429311-luminex-misses-0_06-beats-revenue\" target=\"_blank\">Luminex misses by $0.06, beats on revenue</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429321\" data-linked=\"Luminex Q4 non-GAAP earnings down 81%; shares down 5% after hours\" data-tweet=\"$LMNX - Luminex Q4 non-GAAP earnings down 81%; shares down 5% after hours https://seekingalpha.com/news/3429321-luminex-q4-non-gaap-earnings-down-81-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3429321-luminex-q4-non-gaap-earnings-down-81-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429316\" data-ts=\"1549315843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429316-opko-down-5-after-hours-on-convertible-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OPKO down 5% after hours on convertible debt offering</a></h4><ul><li>OPKO Health (NYSEMKT:<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>) slips <font color=\"red\">5%</font> after hours on the heels of its <a href=\"https://seekingalpha.com/pr/17400985-opko-health-inc-announces-proposed-offering-convertible-senior-notes\" target=\"_blank\">planned offering</a> of $200M aggregate principal amount of Convertible Senior Notes due 2025.</li><li>Price, yield and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429316\" data-linked=\"OPKO down 5% after hours on convertible debt offering\" data-tweet=\"$OPK - OPKO down 5% after hours on convertible debt offering https://seekingalpha.com/news/3429316-opko-down-5-after-hours-on-convertible-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3429316-opko-down-5-after-hours-on-convertible-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429309\" data-ts=\"1549315514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429309-glu-mobileminus-12-after-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile -12% after Q4 loss</a></h4><ul>   <li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) has <font color=\"red\">tumbled 11.9%</font> after hours following a surprise loss and guidance for a sequential bookings drop in its Q4 earnings.</li>    <li>Revenue grew 19% in Q4 but fell just short of consensus, and bookings grew 18% to $98.2M. Full-year bookings hit a record $384.6M.</li>    <li>Net loss was trimmed to $1.3M from a year-ago $39.6M but still trailed consensus.</li>    <li>Free cash flow was $28.9M for the full year.</li>    <li>\"The execution of our Growth Games strategy in 2018 allowed us to deliver stackable bookings and strong adjusted EBITDA profitability,\" says COO/CFO Eric Ludwig.</li>    <li>For Q1, it's guiding to bookings of $88M-$90M; for the full year, it's raised guidance on bookings to $435M-$445M. That full-year guidance includes partial contributions from current beta titles <i>Diner DASH Town</i> and <i>WWE: Universe,</i> but no contribution from a Disney/Pixar title entering beta later in Q1.</li>    <li>The company also announced that it's developing the next-generation title in its <i>Deer Hunter</i> franchise.</li>    <li><a href=\"https://edge.media-server.com/m6/p/b6cs8kde\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429270-glu-mobile-misses-0_02-misses-revenue\" target=\"_blank\">Glu Mobile misses by $0.02, misses on revenue</a> (Feb. 04 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17400928-glu-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3429309\" data-linked=\"Glu Mobile -12% after Q4 loss\" data-tweet=\"$GLUU - Glu Mobile -12% after Q4 loss https://seekingalpha.com/news/3429309-glu-mobileminus-12-after-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3429309-glu-mobileminus-12-after-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429304\" data-ts=\"1549315274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEG\" target=\"_blank\">LEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429304-leggett-and-amp-platt-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leggett &amp;amp; Platt beats by $0.06, beats on revenue</a></h4><ul><li>Leggett &amp; Platt (NYSE:<a href='https://seekingalpha.com/symbol/LEG' title='Leggett & Platt Inc.'>LEG</a>): Q4 Non-GAAP EPS of $0.62 <span style=\"color:green\">beats by $0.06</span>; GAAP EPS of $0.39 <span style=\"color:red\">misses by $0.18</span>.</li><li>Revenue of $1.05B (+6.7% Y/Y) <font color=\"green\">beats by $30M</font>.</li><li>Shares <font color=\"green\">+1.52%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17400981-leggett-and-platt-reports-4q-full-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3429304\" data-linked=\"Leggett &amp;amp; Platt beats by $0.06, beats on revenue\" data-tweet=\"$LEG - Leggett &amp; Platt beats by $0.06, beats on revenue https://seekingalpha.com/news/3429304-leggett-and-amp-platt-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3429304-leggett-and-amp-platt-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429302\" data-ts=\"1549315264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429302-alphabetminus-2_5-despite-q4-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alphabet -2.5% despite Q4 beats</a></h4><ul><li>Alphabet (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>) <font color=\"red\">drops 2.5%</font> aftermarket on Q4 results that beat EPS and revenue estimates with a 22% Y/Y revenue growth.</li><li>Revenue breakdown: Google Properties, $27.02B (consensus: $26.75B); Google Network Members' Properties, $5.6B (consensus: $5.56B); Google Other, $6.5B (consensus: $6.43B); Other Bets, $154M (consensus: $187.4M).</li><li>Traffic acquisition costs or TAC were $7.4B (consensus: $7.62B; up from $6.58B in Q3) or 23% of revenue, down a percentage point from last year's quarter. Google Properties paid clicks grew 86% Y/Y and cost per clicks fell 29%.</li><li>Other key metrics: Operating income, $8.2B (consensus: $8.61B); Operating margin, 21% (consensus: 22.1%).</li><li>Earnings call started at 4:30 PM ET with a webcast available <a href=\"https://abc.xyz/investor/\" target=\"_blank\">here</a>.</li><li><a href=\"https://abc.xyz/investor/static/pdf/2018Q4_alphabet_earnings_release.pdf?cache=adc3b38\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429263-alphabet-beats-1_91-beats-revenue\" target=\"_blank\">Alphabet beats by $1.91, beats on revenue</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429302\" data-linked=\"Alphabet -2.5% despite Q4 beats\" data-tweet=\"$GOOG - Alphabet -2.5% despite Q4 beats https://seekingalpha.com/news/3429302-alphabetminus-2_5-despite-q4-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3429302-alphabetminus-2_5-despite-q4-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>104&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429288\" data-ts=\"1549314981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FN\" target=\"_blank\">FN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429288-fabrinet-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fabrinet beats by $0.05, beats on revenue</a></h4><ul><li>Fabrinet (NYSE:<a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a>): Q2 Non-GAAP EPS of $0.97 <span style=\"color:green\">beats by $0.05</span>; GAAP EPS of $0.84 <span style=\"color:green\">beats by $0.07</span>.</li><li>Revenue of $403.1M (+19.6% Y/Y) <font color=\"green\">beats by $16.88M</font>.</li><li>Shares <font color=\"green\">+1.75%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17400957-fabrinet-announces-second-quarter-fiscal-year-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3429288\" data-linked=\"Fabrinet beats by $0.05, beats on revenue\" data-tweet=\"$FN - Fabrinet beats by $0.05, beats on revenue https://seekingalpha.com/news/3429288-fabrinet-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3429288-fabrinet-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429258\" data-ts=\"1549314977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429258-gilead-down-3-after-hours-on-q4-results-growth-remains-elusive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead down 3% after hours on Q4 results, growth remains elusive</a></h4><ul><li>Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) <a href=\"https://seekingalpha.com/pr/17400889-gilead-sciences-announces-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4 results</a> ($M): Revenues: 5,795 (-2.6%); Product sales: 5,681 (-2.7%).</li><li>Key product sales: Genvoya: 1,206 (+13.8%); Truvada: 823 (+3.3%); Epclusa: 453 (-19.8%); Harvoni 232 (-64.0%); Descovy: 411 (+12.6%); Odefsey: 448 (+37.8%); Biktarvy: 578; Yescarta: 81 (+999%).</li><li>Net income: 3 (+100.1%); non-GAAP net income: 1,873 (-20.1%); EPS: 0 (+100%); non-GAAP EPS: 1.44 (-19.1%).</li><li><strong>2019 guidance</strong>: Product sales: $21.3B - 21.8B.</li><li>Shares are down <font color=\"red\">3%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429262-gilead-sciences-misses-0_26-beats-revenue\" target=\"_blank\">Gilead Sciences misses by $0.26, beats on revenue</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429258\" data-linked=\"Gilead down 3% after hours on Q4 results, growth remains elusive\" data-tweet=\"$GILD - Gilead down 3% after hours on Q4 results, growth remains elusive https://seekingalpha.com/news/3429258-gilead-down-3-after-hours-on-q4-results-growth-remains-elusive?source=tweet\" data-url=\"https://seekingalpha.com/news/3429258-gilead-down-3-after-hours-on-q4-results-growth-remains-elusive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429263\" data-ts=\"1549314186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429263-alphabet-beats-1_91-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alphabet beats by $1.91, beats on revenue</a></h4><ul><li>Alphabet (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>): Q4 GAAP EPS of $12.77 <font color=\"green\">beats by $1.91</font>.</li><li>Revenue of $39.28B (+21.5% Y/Y) <font color=\"green\">beats by $380M</font>.</li><li>Shares <font color=\"green\">+1.9%</font>.</li><li><a href=\"https://abc.xyz/investor/static/pdf/2018Q4_alphabet_earnings_release.pdf?cache=adc3b38\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3429263\" data-linked=\"Alphabet beats by $1.91, beats on revenue\" data-tweet=\"$GOOG $GOOGL $GOOG - Alphabet beats by $1.91, beats on revenue https://seekingalpha.com/news/3429263-alphabet-beats-1_91-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3429263-alphabet-beats-1_91-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>138&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429248\" data-ts=\"1549312718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429248-cowen-points-to-tesla-maxwell-synergy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen points to Tesla-Maxwell synergy</a></h4><ul> <li>Cowen is one of the first research firms out of the box with <a href=\"https://www.barrons.com/articles/teslas-buy-maxwell-technologies-stock-rises-51549295832\" target=\"_blank\">analysis</a> on why Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+0.1%</font>) acquired Maxwell Technologies (<a href='https://seekingalpha.com/symbol/MXWL' title='Maxwell Technologies, Inc.'>MXWL</a> <font color='green'>+49.2%</font>) earlier today.</li> <li>\"We see the deal offering three layers of synergies for Tesla relative to other would be-acquirers,\" notes analyst Jeffrey Osborne on the rare Tesla add-on. \"Namely, applications in automotive, grid applications combining lithium ion batteries and ultracapacitors for grid stabilization and ancillary services, and opportunities for Tesla to improve energy density, and thus range, with Maxwell\u2019s dry electrode capability and graphite expertise,\" he adds.</li> <li>While Maxwell is up around 50% today, shares still trade about 36% below their 52-week high.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429248\" data-linked=\"Cowen points to Tesla-Maxwell synergy\" data-tweet=\"$TSLA $TSLA $MXWL - Cowen points to Tesla-Maxwell synergy https://seekingalpha.com/news/3429248-cowen-points-to-tesla-maxwell-synergy?source=tweet\" data-url=\"https://seekingalpha.com/news/3429248-cowen-points-to-tesla-maxwell-synergy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>126&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429247\" data-ts=\"1549312541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELLI\" target=\"_blank\">ELLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429247-ellie-maeplus-9_5-on-exploring-sale-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ellie Mae +9.5% on exploring a sale - report</a></h4><ul><li>Ellie Mae (NYSEMKT:<a href='https://seekingalpha.com/symbol/ELLI' title='Ellie Mae, Inc.'>ELLI</a>) <font color=\"green\">gains 9.5%</font> after a DealReporter story on Friday said the company hired Morgan Stanley to explore a potential sale, which brought out a flurry of analyst notes.</li><li>RBC (Sector Perform, $80 target) calls the math for a premium acquisition price \"tricky\" but sees the \"rationale\" for the deal as ELLI controls an about 40% share of the U.S. mortgage volume while the market is \"at or near the bottom of the cycle.\"</li><li>JPMorgan (Underweight, $76) thinks a traditional PE deal would be unusual due to the \"typical fundamentals\" sought after that type of transaction. The firm says Ellie faces a couple more quarters of challenging market dynamics.</li><li>Susquehanna (Negative, $53) points out that Morgan Stanley still covers Ellie Mae without restriction, which would typically only be the case if no \"meaningful\" sale progress has been made.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429247\" data-linked=\"Ellie Mae +9.5% on exploring a sale - report\" data-tweet=\"$ELLI - Ellie Mae +9.5% on exploring a sale - report https://seekingalpha.com/news/3429247-ellie-maeplus-9_5-on-exploring-sale-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3429247-ellie-maeplus-9_5-on-exploring-sale-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429245\" data-ts=\"1549311835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRCY\" target=\"_blank\">MRCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429245-mercury-systems-ceo-sells-10000-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercury Systems CEO sells 10,000 shares</a></h4><ul><li>Mercury Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MRCY' title='Mercury Systems, Inc.'>MRCY</a>) CEO Mark Aslett <a href=\"https://seekingalpha.com/filing/4326429\" target=\"_blank\">discloses</a> disposing of 10,000 shares with half at an average price of $58.824 and the rest at $58.273 for a total of about $585.5K.</li><li>MRCY shares are<font color=\"green\"> up 4% </font>to $60.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429245\" data-linked=\"Mercury Systems CEO sells 10,000 shares\" data-tweet=\"$MRCY - Mercury Systems CEO sells 10,000 shares https://seekingalpha.com/news/3429245-mercury-systems-ceo-sells-10000-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3429245-mercury-systems-ceo-sells-10000-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429241\" data-ts=\"1549311285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAT\" target=\"_blank\">USAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429241-usa-tech-csc-announce-cashless-tech-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USA Tech, CSC announce cashless tech agreement</a></h4><ul><li>USA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a>) and CSC ServiceWorks<a href=\"https://seekingalpha.com/pr/17399975-usa-technologies-csc-serviceworks-announce-supply-agreement\" target=\"_blank\"> announce</a> the completion of an ePort supply agreement that has USAT integrating its cashless payment technology into CSC's air vending machines.</li><li>Under the agreement, USA Tech will also upgrade the tech on other CSC machines.</li><li>CSC has over 1.4M commercial laundry and air vending machines in service in multi-family housing units, education centers, and gas stations.</li><li>USAT is<font color=\"green\"> up 8.5%</font> to $6.67.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429241\" data-linked=\"USA Tech, CSC announce cashless tech agreement\" data-tweet=\"$USAT - USA Tech, CSC announce cashless tech agreement https://seekingalpha.com/news/3429241-usa-tech-csc-announce-cashless-tech-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3429241-usa-tech-csc-announce-cashless-tech-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429236\" data-ts=\"1549310565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STON\" target=\"_blank\">STON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429236-stonemor-up-nearly-20-on-financing-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">StoneMor up nearly 20% on financing deal</a></h4><ul><li>The halt came about 10 minutes ago, with <a href='https://seekingalpha.com/symbol/STON' title='StoneMor Partners L.P.'>STON</a> <font color=\"green\">up 4.3%</font>.</li><li>The roughed-up stock is now <font color=\"green\">up about 30%</font> over the past three session.</li><li><strong>Update at 3:21 PM ET:</strong> The company <a href=\"https://seekingalpha.com/filing/4326617\" target=\"_blank\">announces a</a> bank waiver and amendment of certain loan covenants, as well at $35M in financing from Axar Capital along with an agreement for Axar to buy up to 27.5% of the partnership units.</li><li>Shares are now <font color=\"green\">up 18.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429236\" data-linked=\"StoneMor up nearly 20% on financing deal\" data-tweet=\"$STON - StoneMor up nearly 20% on financing deal https://seekingalpha.com/news/3429236-stonemor-up-nearly-20-on-financing-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3429236-stonemor-up-nearly-20-on-financing-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429235\" data-ts=\"1549310525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429235-btig-take-two-benefit-from-videogame-m-wave\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BTIG: Take-Two could benefit from videogame M&amp;A wave</a></h4><ul>   <li>Big tech companies could be set to pursue acquisitions of videogame publishers this year, BTIG's Brandon Ross says, giving special attention to what he sees as perhaps the most attractive candidate: Take-Two Interactive Software (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color=\"green\">+1.7%</font>).</li>    <li>Take-Two stock could leg up even if another publisher is bought by the likes of Microsoft, Amazon.com or Google, Ross writes.</li>    <li>But Take-Two is attractive \"given it is both digestible and has perhaps the best AAA content in the world,\" Ross says. That includes continued success of <i>Red Dead Redemption 2,</i> and Ross expects meaningful contributions for <i>Red Dead Online</i> in fiscal 2020, though scale could limit company margins. (h/t Bloomberg)</li>    <li>He has a Buy rating on TTWO with a price target of $142, implying 33% upside.</li>    <li>Take-Two is set to report earnings on Wednesday, where consensus sees EPS of $2.76 on revenues of $1.51B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429235\" data-linked=\"BTIG: Take-Two could benefit from videogame M&amp;A wave\" data-tweet=\"$TTWO - BTIG: Take-Two could benefit from videogame M&amp;A wave https://seekingalpha.com/news/3429235-btig-take-two-benefit-from-videogame-m-wave?source=tweet\" data-url=\"https://seekingalpha.com/news/3429235-btig-take-two-benefit-from-videogame-m-wave\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429234\" data-ts=\"1549310302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVP\" target=\"_blank\">AVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429234-vibrant-avon-rally-extends-to-third-session\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vibrant Avon rally extends to third session</a></h4><ul> <li>Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) is <font color=\"green\">up 7.6%</font> on the day and is now showing off a three-session gain of over 40% in what Bloomberg reports is the largest advance over the time period in three years.</li> <li>Last week, the company announced updates to its strategic plan and was identified by Bill Miller as a potential \"10 bagger\" for investors to consider.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3429234\" data-linked=\"Vibrant Avon rally extends to third session\" data-tweet=\"$AVP - Vibrant Avon rally extends to third session https://seekingalpha.com/news/3429234-vibrant-avon-rally-extends-to-third-session?source=tweet\" data-url=\"https://seekingalpha.com/news/3429234-vibrant-avon-rally-extends-to-third-session\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429214\" data-ts=\"1549308330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429214-vale-seeks-to-overturn-order-closing-dams-shutting-30m-iron-ore-tons-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale seeks to overturn order closing dams shutting 30M iron ore tons/year</a></h4><ul><li>Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color=\"red\">-4.3%</font>) says a court order <a href=\"https://www.wsj.com/articles/vale-says-order-closing-some-dams-will-halt-30-million-tons-of-iron-ore-output-per-year-11549305534\" target=\"_blank\">forbidding the continued use</a> of some of its tailings dams will remove ~30M metric tons/year of iron ore production.</li><li>A court in Brazil's Minas Gerais state ordered the company to stop adding mining waste and halt any other activity that could increase the risk to the safety of eight of its dams, including three that already were closed because they are the same type of structure as the Brumadinho dam that burst last week.</li><li>Vale says it will take all legal measures necessary to overturn the decision, as the dams affected by the order have the correct licenses and documentation attesting to their stability and there is no technical reason that requires their closure.</li><li>Vale reportedly has <a href=\"https://seekingalpha.com/news/3429034-vale-halts-production-largest-minas-gerais-mine-following-court-order\" target=\"_blank\">halted production</a> at its Brucutu mine, its largest mine in Minas Gerais.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429214\" data-linked=\"Vale seeks to overturn order closing dams shutting 30M iron ore tons/year\" data-tweet=\"$VALE - Vale seeks to overturn order closing dams shutting 30M iron ore tons/year https://seekingalpha.com/news/3429214-vale-seeks-to-overturn-order-closing-dams-shutting-30m-iron-ore-tons-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3429214-vale-seeks-to-overturn-order-closing-dams-shutting-30m-iron-ore-tons-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429216\" data-ts=\"1549307621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YEXT\" target=\"_blank\">YEXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429216-software-names-gain-on-ultimate-software-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Software names gain on Ultimate Software acquisition</a></h4><ul><li>Software and service names on the move after this morning's news that Ultimate Software agreed to be acquired for $11B.</li><li>Among the movers: (<a href='https://seekingalpha.com/symbol/YEXT' title='Yext, Inc.'>YEXT</a> <font color='green'>+5.7%</font>), (<a href='https://seekingalpha.com/symbol/GDDY' title='GoDaddy Inc.'>GDDY</a> <font color='green'>+2.5%</font>), (<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Inc'>COUP</a> <font color='green'>+1.5%</font>), (<a href='https://seekingalpha.com/symbol/EB' title='Eventbrite'>EB</a> <font color='green'>+6.3%</font>), (<a href='https://seekingalpha.com/symbol/SVMK' title='SurveyMonkey'>SVMK</a> <font color='green'>+5.5%</font>), (<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a> <font color='green'>+5.3%</font>), (<a href='https://seekingalpha.com/symbol/TWOU' title='2U, Inc.'>TWOU</a> <font color='green'>+5.2%</font>), (<a href='https://seekingalpha.com/symbol/PS' title='Pluralsight, Inc.'>PS</a> <font color='green'>+3.9%</font>), (<a href='https://seekingalpha.com/symbol/ESTC' title='Elastic'>ESTC</a> <font color='green'>+3.4%</font>), (<a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a> <font color='green'>+3.4%</font>), (<a href='https://seekingalpha.com/symbol/QLYS' title='Qualys'>QLYS</a> <font color='green'>+3.5%</font>), (<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a> <font color='green'>+3.4%</font>).</li><li>Related software ETFs: <a href='https://seekingalpha.com/symbol/IGV' title='iShares Expanded Tech-Software Sector ETF'>IGV</a>, <a href='https://seekingalpha.com/symbol/PSJ' title='Invesco Dynamic Software Portfolio ETF'>PSJ</a>, <a href='https://seekingalpha.com/symbol/XSW' title='SPDR Software & Services ETF'>XSW</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3428952-ultimate-software-agrees-11b-acquisition\" target=\"_blank\">Ultimate Software agrees to $11B acquisition</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429216\" data-linked=\"Software names gain on Ultimate Software acquisition\" data-tweet=\"$YEXT $YEXT $GDDY - Software names gain on Ultimate Software acquisition https://seekingalpha.com/news/3429216-software-names-gain-on-ultimate-software-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3429216-software-names-gain-on-ultimate-software-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429209\" data-ts=\"1549307370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABMD\" target=\"_blank\">ABMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429209-abiomed-down-6-on-cautious-provider-letter-impella-heart-pump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abiomed down 6% on cautious provider letter about Impella heart pump</a></h4><ul><li>ABIOMED (<a href='https://seekingalpha.com/symbol/ABMD' title='ABIOMED, Inc.'>ABMD</a> <font color=\"red\">-5.7%</font>) is down on average volume in apparent response to an <a href=\"https://www.fda.gov/MedicalDevices/Safety/LetterstoHealthCareProviders/ucm630610.htm\" target=\"_blank\">FDA letter</a> to healthcare providers cautioning on an increase in mortality in patients using the Impella RP heart pump in a post-market study. The agency says it is evaluating the situation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429209\" data-linked=\"Abiomed down 6% on cautious provider letter about Impella heart pump\" data-tweet=\"$ABMD - Abiomed down 6% on cautious provider letter about Impella heart pump https://seekingalpha.com/news/3429209-abiomed-down-6-on-cautious-provider-letter-impella-heart-pump?source=tweet\" data-url=\"https://seekingalpha.com/news/3429209-abiomed-down-6-on-cautious-provider-letter-impella-heart-pump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429204\" data-ts=\"1549306850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZKIN\" target=\"_blank\">ZKIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429204-zk-international-and-sanchez-midstream-partners-among-energy-materials-gainers-mountain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZK International and Sanchez Midstream Partners among Energy/Materials gainers; Mountain Province Diamonds and Ossen Innovation among losers</a></h4><ul><li><b>Gainers: </b>ZK International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"green\">+16%</font>. Sanchez Midstream Partners (NYSEMKT:<a href='https://seekingalpha.com/symbol/SNMP' title='Sanchez Midstream Partners LP'>SNMP</a>) <font color=\"green\">+10%</font>. Aemetis (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a>) <font color=\"green\">+10%</font>. Covia (NYSE:<a href='https://seekingalpha.com/symbol/CVIA' title='Covia Holdings Corporation'>CVIA</a>) <font color=\"green\">+8%</font>. DRDGOLD (NYSE:<a href='https://seekingalpha.com/symbol/DRD' title='DRDGOLD Limited'>DRD</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-11%</font>. Ossen Innovation (NASDAQ:<a href='https://seekingalpha.com/symbol/OSN' title='Ossen Innovation Co., Ltd.'>OSN</a>) <font color=\"red\">-8%</font>. Valhi (NYSE:<a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a>) <font color=\"red\">-7%</font>. AngloGold Ashanti (NYSE:<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a>) <font color=\"red\">-6%</font>. Platinum Group Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLG' title='Platinum Group Metals Ltd'>PLG</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429204\" data-linked=\"ZK International and Sanchez Midstream Partners among Energy/Materials gainers; Mountain Province Diamonds and Ossen Innovation among losers\" data-tweet=\"$ZKIN $ZKIN $SNMP - ZK International and Sanchez Midstream Partners among Energy/Materials gainers; Mountain Province Diamonds and Ossen Innovation among losers https://seekingalpha.com/news/3429204-zk-international-and-sanchez-midstream-partners-among-energy-materials-gainers-mountain?source=tweet\" data-url=\"https://seekingalpha.com/news/3429204-zk-international-and-sanchez-midstream-partners-among-energy-materials-gainers-mountain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429202\" data-ts=\"1549306692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRON\" target=\"_blank\">CRON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429202-cronos-leading-pot-stock-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cronos leading pot stock rally</a></h4><ul><li>Cronos Group (<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color=\"green\">+18.1%</font>) is leading a rally in pot producers. Shares have more than doubled this year. Short sellers are, no doubt, feeling some pain, at least in the short term.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color=\"green\">+7.5%</font>)(<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color=\"green\">+4.5%</font>)(<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"green\">+10.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429202\" data-linked=\"Cronos leading pot stock rally\" data-tweet=\"$CRON $TLRY $CGC - Cronos leading pot stock rally https://seekingalpha.com/news/3429202-cronos-leading-pot-stock-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3429202-cronos-leading-pot-stock-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>147&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429183\" data-ts=\"1549305458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429183-roku-marks-double-digit-gain-amid-executive-change-comcast-streaming-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku marks double-digit gain amid executive change, Comcast streaming report</a></h4><ul>   <li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) is on the move today, <font color=\"green\">up 10%</font>, in the wake of a executive change and a weekend report suggesting Comcast would stick with a Roku-based technology rather than developing an Apple TV app.</li>    <li>BestAppleTV <a href=\"https://www.bestappletv.com/news/exclusive-after-passing-on-apple-tv-for-roku-comcast-wont-develop-a-tvos-app-for-its-21-million-cable-customers/\" target=\"_blank\">reported</a> that Comcast wouldn't build a tvOS app to stream its cable systems, after the company previously said it would pass on using Apple TV as an infrastructure for streaming.</li>    <li>Instead, Comcast will tap the Now TV streaming system of recent acquisition Sky, which is offered via a Roku-powered device, according to the report.</li>    <li>\"Our idea to enter the business is to leverage Sky's technology ... We think this approach has a much better chance to get scale quickly,\" NBCUniversal's Steven Burke said in <a href=\"https://seekingalpha.com/article/4235087-comcast-corporation-cmcsa-ceo-brian-roberts-q4-2018-results-earnings-call-transcript\" target=\"_blank\">Comcast's earnings call</a>, and BestAppleTV reconfirmed with sources that the company doesn't plan a stand-alone tvOS app.</li>    <li>Earlier today, Roku said it's <a href=\"https://seekingalpha.com/pr/17400302-roku-announces-mustafa-ozgen-joins-gm-svp-account-acquisition\" target=\"_blank\">adding Mustafa Ozgen</a>, currently CEO of SmartKem Limited, to replace its senior VP and general manager of Roku TVs and Player Chas Smith.</li>    <li>Ozgen's title will be senior VP and GM of Account Acquisition. Smith will retire and exit at the end of the quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429183\" data-linked=\"Roku marks double-digit gain amid executive change, Comcast streaming report\" data-tweet=\"$ROKU - Roku marks double-digit gain amid executive change, Comcast streaming report https://seekingalpha.com/news/3429183-roku-marks-double-digit-gain-amid-executive-change-comcast-streaming-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3429183-roku-marks-double-digit-gain-amid-executive-change-comcast-streaming-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429150\" data-ts=\"1549303823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429150-therapix-bio-up-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapix Bio up 26%</a></h4><ul><li>Thinly traded nano cap Therapix Biosciences (<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color=\"green\">+26%</font>) is up on more than double normal volume, albeit on turnover of only 218K shares, on no particular news.</li><li>The company develops cannabinoid therapies for CNS disorders. Lead candidate is THX-110, a combination of the cannabinoid dronabinol and palmitoylethanolamide &#40;PEA&#41;, a cannabinoid mimetic, for the treatment of Tourette syndrome, obstructive sleep apnea and pain.</li><li>In December, it <a href=\"https://seekingalpha.com/news/3418813-therapix-biosciences-scraps-deal-fsd-pharma\" target=\"_blank\">backed out</a> of a deal to be acquired by FSD Pharma.</li><li>Last summer, it filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1611746/000121390018010534/f424b2072018_therapixbio.htm\" target=\"_blank\">prospectus </a>for a $50M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429150\" data-linked=\"Therapix Bio up 26%\" data-tweet=\"$TRPX - Therapix Bio up 26% https://seekingalpha.com/news/3429150-therapix-bio-up-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3429150-therapix-bio-up-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429147\" data-ts=\"1549303258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DS\" target=\"_blank\">DS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429147-dunxin-financial-holdings-leads-financial-gainers-x-financial-and-stewart-information\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dunxin Financial Holdings leads financial gainers; X Financial and Stewart Information Services among losers</a></h4><ul><li><b>Gainers: </b>Dunxin Financial Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/DXF' title='Dunxin Financial Holdings Limited'>DXF</a>) <font color=\"green\">+9%</font>. Drive Shack (NYSE:<a href='https://seekingalpha.com/symbol/DS' title='Drive Shack Inc'>DS</a>) <font color=\"green\">+6%</font>. Live Oak Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/LOB' title='Live Oak Bancshares'>LOB</a>) <font color=\"green\">+6%</font>. Loop Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LOOP' title='Loop Industries, Inc.'>LOOP</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Medley Management (NYSE:<a href='https://seekingalpha.com/symbol/MDLY' title='Medley Management'>MDLY</a>) <font color=\"red\">-24%</font>. Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"red\">-9%</font>. Stewart Information Services (NYSE:<a href='https://seekingalpha.com/symbol/STC' title='Stewart Information Services Corporation'>STC</a>) <font color=\"red\">-7%</font>. Wheeler Real Estate Investment Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a>) <font color=\"red\">-6%</font>. X Financial (NYSE:<a href='https://seekingalpha.com/symbol/XYF' title='X Financial'>XYF</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429147\" data-linked=\"Dunxin Financial Holdings leads financial gainers; X Financial and Stewart Information Services among losers\" data-tweet=\"$DS $DXF $DS - Dunxin Financial Holdings leads financial gainers; X Financial and Stewart Information Services among losers https://seekingalpha.com/news/3429147-dunxin-financial-holdings-leads-financial-gainers-x-financial-and-stewart-information?source=tweet\" data-url=\"https://seekingalpha.com/news/3429147-dunxin-financial-holdings-leads-financial-gainers-x-financial-and-stewart-information\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429144\" data-ts=\"1549302843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXWL\" target=\"_blank\">MXWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429144-microcaps-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate midday movers</a></h4><ul><li><strong>Gainers:</strong> Maxwell Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MXWL' title='Maxwell Technologies, Inc.'>MXWL</a>) <font color=\"green\">+50%</font>. Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a>) <font color=\"green\">+24%</font>. Continental Materials (NYSEMKT:<a href='https://seekingalpha.com/symbol/CUO' title='Continental Materials Corp'>CUO</a>) <font color=\"green\">+24%</font>. PHI (NASDAQ:<a href='https://seekingalpha.com/symbol/PHII' title='PHI, Inc.'>PHII</a>) <font color=\"green\">+22%</font>. Orgenesis (NASDAQ:<a href='https://seekingalpha.com/symbol/ORGS' title='Orgenesis, Inc.'>ORGS</a>) <font color=\"green\">+19%</font>. The Ultimate Software Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ULTI' title='Ultimate Software Group, Inc. &#40;The&#41;'>ULTI</a>) <font color=\"green\">+20%</font>. Aileron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a>) <font color=\"green\">+19%</font>. Horizon Global (NYSE:<a href='https://seekingalpha.com/symbol/HZN' title='Horizon Global Corp'>HZN</a>) <font color=\"green\">+18%</font>. Napco Security Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NSSC' title='NAPCO Security Technologies, Inc.'>NSSC</a>) <font color=\"green\">+17%</font>. AAC Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AAC' title='AAC Holdings, Inc.'>AAC</a>) <font color=\"green\">+17%</font>.</li><li><strong>Losers: </strong>Check-Cap (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a>) <font color=\"red\">-27%</font>. Medley Management (NYSE:<a href='https://seekingalpha.com/symbol/MDLY' title='Medley Management'>MDLY</a>) <font color=\"red\">-23%</font>. TMSR Holding Company (NASDAQ:<a href='https://seekingalpha.com/symbol/TMSR' title='TMSR Holding Co., Ltd.'>TMSR</a>) <font color=\"red\">-22%</font>. Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a>) <font color=\"red\">-15%</font>. Organogenesis Holdings (<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc'>ORGO</a>) <font color=\"red\">-12%</font>. China SXT Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a>) <font color=\"red\">-12%</font>. Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-11%</font>. American Superconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/AMSC' title='American Superconductor Corporation'>AMSC</a>) <font color=\"red\">-12%</font>. Novus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NVUS' title='Novus Therapeutics'>NVUS</a>) <font color=\"red\">-11%</font>. Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>) <font color=\"red\">-10%</font>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3429144\" data-linked=\"Microcaps dominate midday movers\" data-tweet=\"$MXWL $MXWL $TRPX - Microcaps dominate midday movers https://seekingalpha.com/news/3429144-microcaps-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3429144-microcaps-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429142\" data-ts=\"1549302648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHII\" target=\"_blank\">PHII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429142-phi-inplus-22-in-high-volume-breakout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PHI in +22% in high-volume breakout</a></h4><ul> <li>PHI (NASDAQ:<a href='https://seekingalpha.com/symbol/PHII' title='PHI, Inc.'>PHII</a>) shoots <font color=\"green\">up 22%</font> to trade at its highest level of the year.</li> <li>Trading volume on the helicopter services stock is very high and was volatile enough to prompt a Nasdaq trading halt earlier in the day.</li> <li>PHI is expected to report earnings in the middle part of March.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429142\" data-linked=\"PHI in +22% in high-volume breakout\" data-tweet=\"$PHII - PHI in +22% in high-volume breakout https://seekingalpha.com/news/3429142-phi-inplus-22-in-high-volume-breakout?source=tweet\" data-url=\"https://seekingalpha.com/news/3429142-phi-inplus-22-in-high-volume-breakout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429140\" data-ts=\"1549302420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429140-abeona-up-13-ahead-of-gene-therapy-presentations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abeona up 13% ahead of gene therapy presentations</a></h4><ul><li>Abeona Therapeutics (<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color=\"green\">+13.2%</font>) is up on average volume ahead of <a href=\"https://investors.abeonatherapeutics.com/press-releases/detail/144/abeona-therapeutics-to-present-new-supportive-data-for\" target=\"_blank\">posters and presentations</a> on its gene therapy candidates at the WORLDSymposium in Orlando, FL.</li><li>February 5: Three posters on gene therapy candidates in Pompe disease, Fabry and CLN3 juvenile neuronal ceroid lipofuscinosis.</li><li>February 6: One poster on MPS IIIA and two presentations, one related to preclinical data in infantile neuronal ceroid lipofuscinosis and the other pertaining to Phase 1/2 data on scAAV9.U1a.hSGSH in MPS IIIA<em>. </em></li></ul><div class=\"tiny-share-widget\" data-id=\"3429140\" data-linked=\"Abeona up 13% ahead of gene therapy presentations\" data-tweet=\"$ABEO - Abeona up 13% ahead of gene therapy presentations https://seekingalpha.com/news/3429140-abeona-up-13-ahead-of-gene-therapy-presentations?source=tweet\" data-url=\"https://seekingalpha.com/news/3429140-abeona-up-13-ahead-of-gene-therapy-presentations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429139\" data-ts=\"1549302179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429139-baird-election-boost-to-help-twitter-q4-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird: Election boost to help Twitter Q4 revenues</a></h4><ul>   <li>When Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color=\"green\">+2.5%</font>) reports earnings this Thursday morning, it's likely to see a meet-or-beat on revenue expectations from Baird, the analysts say, thanks in part to an audience boost from the U.S. election.</li>    <li>Baird's estimate of $874M is already on the higher side of the Street (FactSet consensus is $867.7M). But analyst Colin Sebastian notes the company continues to invest in improvement.</li>    <li>\u201cTogether with the viral nature of Twitter and the strong push by media companies to engage users on the application, we believe there is solid visibility for growth in number of users and time spent on the application,\u201d Sebastian writes. (h/t Bloomberg)</li>    <li>He has a Neutral rating and $35 price target, implying just 2.9% upside from current pricing.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429074-twitters-dorsey-says-considering-edit-feature\" target=\"_blank\">Twitter's Dorsey says they're considering edit feature</a> (Feb. 04 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429139\" data-linked=\"Baird: Election boost to help Twitter Q4 revenues\" data-tweet=\"$TWTR - Baird: Election boost to help Twitter Q4 revenues https://seekingalpha.com/news/3429139-baird-election-boost-to-help-twitter-q4-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3429139-baird-election-boost-to-help-twitter-q4-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429129\" data-ts=\"1549300817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLNKY\" target=\"_blank\">BLNKY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429129-taptica-to-buy-out-rhythmone-for-177m-in-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taptica to buy out RhythmOne for $177M in stock</a></h4><ul>   <li>Mobile video ad firm RhythmOne (<a href='https://seekingalpha.com/symbol/BLNKY' title='Rhythmone PLC ADR'>OTC:BLNKY</a>) is set to be bought out by Taptica International (<a href='https://seekingalpha.com/symbol/TTTPF' title='TAPTICA INTL LTD ORD'>OTCPK:TTTPF</a>) <a href=\"https://www.yahoo.com/news/video-advertiser-taptica-says-merge-rhythmone-081559710--finance.html\" target=\"_blank\">for about £135M</a> (about $176.6M) in stock.</li>    <li>That will give Taptica a line into U.S. expansion, including through RhythmOne-owned online TV provider YuMe. Taptica had bought Tremor Video's demand-side platform in August.</li>    <li>RhythmOne shareholders will get 28 new Taptica shares for every 33 RhythmOne shares held.</li>    <li>Taptica says the deal already has the backing of 46.6% of its shareholders and 50.95% of RhythmOne. It plans to launch a $15M buyback as soon as the offer's complete.</li>    <li>Meanwhile, RhythmOne CFO Mark Zorko is reportedly departing after a few months in the role, though he will remain available to enable a smooth transition. CEO Mark Bonney will take over as interim CFO effective today.</li>    <li><a href='https://seekingalpha.com/symbol/BLNKF' title='RHYTHMONE PLC ORD NEW'>OTCPK:BLNKF</a> <font color=\"green\">+14.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429129\" data-linked=\"Taptica to buy out RhythmOne for $177M in stock\" data-tweet=\"$BLNKY $TTTPF $BLNKF - Taptica to buy out RhythmOne for $177M in stock https://seekingalpha.com/news/3429129-taptica-to-buy-out-rhythmone-for-177m-in-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3429129-taptica-to-buy-out-rhythmone-for-177m-in-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429119\" data-ts=\"1549299955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WKHS\" target=\"_blank\">WKHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429119-workhorse-rallies-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workhorse rallies 10%</a></h4><ul> <li>Workhorse Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a>) jumps back $1.00 with a <font color=\"green\">10% gain</font> on the day.</li><li>Volume on WKHS is above normal activity.</li> <li>There isn't any specific news out from Workhorse and the company isn't expected to report Q4 earnings until the early part of March.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3429119\" data-linked=\"Workhorse rallies 10%\" data-tweet=\"$WKHS - Workhorse rallies 10% https://seekingalpha.com/news/3429119-workhorse-rallies-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3429119-workhorse-rallies-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429116\" data-ts=\"1549299690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONO\" target=\"_blank\">SONO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429116-avon-products-and-clorox-among-consumer-gainers-westport-fuel-system-and-pitney-bowes-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon Products and Clorox among consumer gainers; Westport Fuel System and Pitney Bowes in losers</a></h4><ul><li><b>Gainers: </b>Sonos (NASDAQ:<a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a>) <font color=\"green\">+7%</font>. Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) <font color=\"green\">+7%</font>. The Clorox (NYSE:<a href='https://seekingalpha.com/symbol/CLX' title='The Clorox Company'>CLX</a>) <font color=\"green\">+7%</font>. New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"green\">+6%</font>. Fox Factory Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/FOXF' title='Fox Factory Holding Corp'>FOXF</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a>) <font color=\"red\">-15%</font>. Pitney Bowes (NYSE:<a href='https://seekingalpha.com/symbol/PBI' title='Pitney Bowes Inc.'>PBI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429116\" data-linked=\"Avon Products and Clorox among consumer gainers; Westport Fuel System and Pitney Bowes in losers\" data-tweet=\"$SONO $SONO $AVP - Avon Products and Clorox among consumer gainers; Westport Fuel System and Pitney Bowes in losers https://seekingalpha.com/news/3429116-avon-products-and-clorox-among-consumer-gainers-westport-fuel-system-and-pitney-bowes-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3429116-avon-products-and-clorox-among-consumer-gainers-westport-fuel-system-and-pitney-bowes-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429110\" data-ts=\"1549299067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSU\" target=\"_blank\">TSU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429110-tim-brazil-unit-set-to-return-labriola-to-board-after-short-absence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TIM Brazil unit set to return Labriola to board after short absence</a></h4><ul>   <li>TIM Participações (<a href=\"http://seekingalpha.com/symbol/TSU\" target=\"_blank\">TSU</a> <font color=\"red\">-0.1%</font>) -- the Brazilian unit of Telecom Italia (<a href=\"http://seekingalpha.com/symbol/TI\" target=\"_blank\">TI</a> <font color=\"green\">+2%</font>) -- will return former Chief Operating Officer Pietro Labriola to its board after a three-month absence, Bloomberg reports.</li>    <li>Labriola was seen as key to TIM's resurgence, but resigned in October when Amos Genish was CEO of Telecom Italia. That was before Genish's ouster and <a href=\"https://seekingalpha.com/news/3410900-telecom-italia-plus-3_8-percent-ceo-choice-suggests-new-direction\" target=\"_blank\">replacement by Luigi Gubitosi</a>, as Elliott Management took control of TI's board from top shareholder Vivendi (<a href=\"http://seekingalpha.com/symbol/VIVHY\" target=\"_blank\">VIVHY</a> <font color=\"green\">+0.4%</font>).</li>    <li>Labriola, a TI veteran who took over as COO of the Brazil business in 2015, could return to the Brazil unit's board as soon as this week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429110\" data-linked=\"TIM Brazil unit set to return Labriola to board after short absence\" data-tweet=\"$TSU $TSU $TI - TIM Brazil unit set to return Labriola to board after short absence https://seekingalpha.com/news/3429110-tim-brazil-unit-set-to-return-labriola-to-board-after-short-absence?source=tweet\" data-url=\"https://seekingalpha.com/news/3429110-tim-brazil-unit-set-to-return-labriola-to-board-after-short-absence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429109\" data-ts=\"1549299059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429109-celgene-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene down 3%</a></h4><ul><li>Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color=\"red\">-2.8%</font>) is down on modestly higher volume in apparent to response to the potential <a href=\"https://www.cnbc.com/2019/02/04/bristol-myers-squibb-shares-pop-on-report-starboard-value-has-taken.html\" target=\"_blank\">involvement</a> of activist investor Starboard Value via a rumored stake in acquirer Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"green\">+0.3%</font>). Investors are behaving as if Starboard may not be in favor of the $74B tie-up.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429109\" data-linked=\"Celgene down 3%\" data-tweet=\"$CELG $BMY - Celgene down 3% https://seekingalpha.com/news/3429109-celgene-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3429109-celgene-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429102\" data-ts=\"1549298517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429102-overstocks-medici-land-governance-signs-mou-mexican-municipality\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock&#39;s Medici Land Governance signs MOU with Mexican municipality</a></h4><ul><li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>)<font color=\"green\"> jumps 4.4%</font> after announcing that its blockchain-based property rights unit, Medici Land Governance, <a href=\"https://seekingalpha.com/pr/17400358-overstock-com-subsidiary-medici-land-governance-signs-agreement-build-next-generation-land\" target=\"_blank\">signed an MOU </a>with a Mexican municipality to develop a digital land records platform.</li><li>The MOU with the municipality of Tulum in Quintana Roo, Mexico, contemplates collecting real property ownership information for a defined area of Tulum to protect the land rights of its citizens.</li><li>The project would entail mass issuance of title to and related processes. Medici Land and Tulum officials will also collaborate to create a method for automatically capturing and recording subsequent land administration transactions and updates to the digital platform.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3418502-overstock-com-pact-blockchain-based-property-information-platform\" target=\"_blank\">Overstock.com in pact for blockchain-based property information platform</a> (Dec. 20, 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429102\" data-linked=\"Overstock&#39;s Medici Land Governance signs MOU with Mexican municipality\" data-tweet=\"$OSTK - Overstock&#39;s Medici Land Governance signs MOU with Mexican municipality https://seekingalpha.com/news/3429102-overstocks-medici-land-governance-signs-mou-mexican-municipality?source=tweet\" data-url=\"https://seekingalpha.com/news/3429102-overstocks-medici-land-governance-signs-mou-mexican-municipality\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429094\" data-ts=\"1549296184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EOLS\" target=\"_blank\">EOLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429094-evolus-leads-healthcare-gainers-fortress-biotech-and-check-cap-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evolus leads healthcare gainers; Fortress Biotech and Check-Cap among losers</a></h4><ul><li><b>Gainers: </b>Evolus (NASDAQ:<a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a>) <font color=\"green\">+20%</font>. Arvinas Holding Company (NASDAQ:<a href='https://seekingalpha.com/symbol/ARVN' title='Arvinas'>ARVN</a>) <font color=\"green\">+14%</font>. Constellation Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNST' title='Constellation Pharmaceuticals'>CNST</a>) <font color=\"green\">+13%</font>. Avadel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) <font color=\"green\">+12%</font>. Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Check-Cap (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a>) <font color=\"red\">-25%</font>. Organogenesis Holdings (<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc'>ORGO</a>) <font color=\"red\">-14%</font>. China SXT Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a>) <font color=\"red\">-12%</font>. Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>) <font color=\"red\">-8%</font>. Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429094\" data-linked=\"Evolus leads healthcare gainers; Fortress Biotech and Check-Cap among losers\" data-tweet=\"$EOLS $EOLS $ARVN - Evolus leads healthcare gainers; Fortress Biotech and Check-Cap among losers https://seekingalpha.com/news/3429094-evolus-leads-healthcare-gainers-fortress-biotech-and-check-cap-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3429094-evolus-leads-healthcare-gainers-fortress-biotech-and-check-cap-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429085\" data-ts=\"1549294922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLX\" target=\"_blank\">CLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429085-cloroxplus-7-after-showing-off-margin-improvement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clorox +7% after showing off margin improvement</a></h4><ul> <li>Clorox (NYSE:<a href='https://seekingalpha.com/symbol/CLX' title='The Clorox Company'>CLX</a>) is <font color=\"green\">up 7.4%</font> after investors latch on to the company's Q4 EPS beat and reffirmed guidance (FY19 revenue growth +2% to +4% vs. +3.2% consensus, EPS of $6.20 to $6.40 vs. $6.32 consensus).</li> <li>Clorox's Q4 margin rate of 43.7% topped last year's mark of 43.0% and was ahead of the consensus estimate of 42.2%.</li> <li>Shares of Clorox are trade at their highest level of 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428931-cloroxs-q2-bottom-line-beat\" target=\"_blank\">More on Clorox's Q2 bottom-line beat</a> (Feb. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429085\" data-linked=\"Clorox +7% after showing off margin improvement\" data-tweet=\"$CLX - Clorox +7% after showing off margin improvement https://seekingalpha.com/news/3429085-cloroxplus-7-after-showing-off-margin-improvement?source=tweet\" data-url=\"https://seekingalpha.com/news/3429085-cloroxplus-7-after-showing-off-margin-improvement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429084\" data-ts=\"1549294686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMG\" target=\"_blank\">AMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429084-affiliated-managersplus-2_8-after-share-buyback-dividend-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Affiliated Managers +2.8% after share buyback, dividend boost</a></h4><ul><li>Affiliated Managers Group (NYSE:<a href='https://seekingalpha.com/symbol/AMG' title='Affiliated Managers Group'>AMG</a>) <font color=\"green\">rises 2.8%</font> <a href=\"https://seekingalpha.com/pr/17399998-amg-reports-financial-operating-results-fourth-quarter-full-year-2018\" target=\"_blank\">after Q4 economic EPS</a> beats the consensus estimate and its board increases its share repurchase authorization to 5M shares and boosts dividend by 6.7%.</li><li><a href=\"https://seekingalpha.com/news/3428965-affiliated-managers-beats-0_02-misses-revenue\" target=\"_blank\"> Q4 economic EPS of $3.53 </a>vs. estimate of $3.51; compares with $4.68 in the year-ago period.</li><li>Q4 net client cash outflows were $15.8B and market changes reduced assets under management by $67.5B during the quarter; AUM of $736B at Dec. 31, 2018 vs. $829.6B at Sept. 30, 2018.</li><li>Q4 adjusted EBITDA of $191.3M vs. $361.3M a year ago.</li><li>Q4 aggregate fees of $1.2B slips from $1.7B in the year-ago period.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428973-affiliated-managers-declares-0_32-dividend\" target=\"_blank\">Affiliated Managers declares $0.32 dividend</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429084\" data-linked=\"Affiliated Managers +2.8% after share buyback, dividend boost\" data-tweet=\"$AMG - Affiliated Managers +2.8% after share buyback, dividend boost https://seekingalpha.com/news/3429084-affiliated-managersplus-2_8-after-share-buyback-dividend-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3429084-affiliated-managersplus-2_8-after-share-buyback-dividend-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429081\" data-ts=\"1549293919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCI\" target=\"_blank\">GCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429081-mng-responds-harshly-to-gannetts-bid-rejection\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MNG responds harshly to Gannett&#39;s bid rejection</a></h4><ul>   <li>MNG Enterprises says Gannett (<a href=\"http://seekingalpha.com/symbol/GCI\" target=\"_blank\">GCI</a> <font color=\"red\">-4.6%</font>) has <a href=\"https://seekingalpha.com/pr/17400514-mng-enterprises-responds-gannett-s-rejection-mng-s-cash-proposal\" target=\"_blank\">\"no credible plan\" to get to $12/share</a> on its own, a response to the company's <a href=\"https://seekingalpha.com/news/3428988-gannett-rejects-mng-bid\" target=\"_blank\">rejection of MNG's offer</a> at that price.</li>    <li>\"Gannett\u2019s Board today sent shareholders a clear message: that it intends to block immediate and certain value creation opportunities in favor of a speculative future engineered by the team that already has destroyed over 40% of the Company\u2019s value,\" MNG says in its statement.</li>    <li>Gannett's \"pie in the sky\" hopes for digital businesses aren't believable, MNG continues, saying management is presiding over a declining core business, decreasing cash flow and significant leverage.</li>    <li>And following through on <a href=\"https://seekingalpha.com/news/3424260-report-alden-readies-opposing-slate-gannett-resists-bid\" target=\"_blank\">previous pressure</a> on the board, MNG says it will consider its options, including nominating a more agreeable slate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429081\" data-linked=\"MNG responds harshly to Gannett&#39;s bid rejection\" data-tweet=\"$GCI - MNG responds harshly to Gannett&#39;s bid rejection https://seekingalpha.com/news/3429081-mng-responds-harshly-to-gannetts-bid-rejection?source=tweet\" data-url=\"https://seekingalpha.com/news/3429081-mng-responds-harshly-to-gannetts-bid-rejection\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429080\" data-ts=\"1549293894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UFI\" target=\"_blank\">UFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429080-on-unifis-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Unifi&#39;s Q2 results</a></h4><ul><li>Unifi (<a href='https://seekingalpha.com/symbol/UFI' title='Unifi Inc'>UFI</a> <font color=\"green\">+2.5%</font>) reported Q2 net sales of $167.7M, a slight increase from last year; revenues from premium value-added products represented ~47% of the sales.</li><li>Sales by segments: Polyester $85.79M (-5% Y.Y); Nylon $22.65M (-9.8% Y/Y); International $58.24M (+14.1% Y/Y); and All Other $1.04M (+2.5%).</li><li>Q2 Gross margin<font color=\"red\"> declined by 510 bps</font> to 8.4%, decrease was attributable to lower regional yarn volumes driving weaker fixed cost absorption, higher polyester raw material costs and a weaker sales mix.</li><li>Adj. EBITDA decreased by 65% Y/Y to $4.85M and margin <font color=\"red\">declined by 540 bps</font> to 2.9%.</li><li>Net cash used in by operating activities YTD was $3.97M, compared to cash provided $20.39M a year ago.</li><li>Company has cash and cash equivalents of $26.65M, as of December 30, 2018.</li><li><strong>FY19 Outlook:</strong> Mid-single-digit percentage growth for net sales; operating income $19M to $23M; Adj. EBITDA $42M to $46M; Capex of ~$25M and effective tax rate in mid-40% range.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428918-unifi-beats-0_11-beats-revenue\" target=\"_blank\">Unifi beats by $0.11, beats on revenue</a> (Feb. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429080\" data-linked=\"More on Unifi&#39;s Q2 results\" data-tweet=\"$UFI - More on Unifi&#39;s Q2 results https://seekingalpha.com/news/3429080-on-unifis-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3429080-on-unifis-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429076\" data-ts=\"1549293417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANGI\" target=\"_blank\">ANGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429076-angiplus-1_7-on-goldman-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ANGI +1.7% on Goldman start</a></h4><ul><li>Goldman reinstates ANGI Homeservices (NASDAQ:<a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a>) at Buy with a $20 target, an 18% upside.</li><li>The firm restarts ANGI's parent IAC (NASDAQ:<a href='https://seekingalpha.com/symbol/IAC' title='IAC/InterActiveCorp'>IAC</a>) at Neutral with a $226 target, a 7% upside.</li><li>ANGI will <a href=\"https://seekingalpha.com/symbol/ANGI/earnings\" target=\"_blank\">report earnings</a> on February 7 and consensus estimates put revenue at $280.74M with $0.03 EPS.</li><li>ANGI shares are <font color=\"green\">up 1.7%</font> to $17.23.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429076\" data-linked=\"ANGI +1.7% on Goldman start\" data-tweet=\"$ANGI $ANGI $IAC - ANGI +1.7% on Goldman start https://seekingalpha.com/news/3429076-angiplus-1_7-on-goldman-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3429076-angiplus-1_7-on-goldman-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429071\" data-ts=\"1549292968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFLY\" target=\"_blank\">SFLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429071-goldman-restarts-shutterfly-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman restarts Shutterfly at Sell</a></h4><ul><li>Goldman Sachs reinstates Shutterfly (NASDAQ:<a href='https://seekingalpha.com/symbol/SFLY' title='Shutterfly, Inc.'>SFLY</a>) at a Sell rating and $40, a 10% downside.</li><li>On Friday, SunTrust <a href=\"https://seekingalpha.com/news/3428708-shutterfly-minus-2_7-percent-suntrust-cut\" target=\"_blank\">cut</a> its Shutterfly target ahead of earnings with checks showing weaker than expected revenue growth.</li><li>Shutterfly will <a href=\"https://seekingalpha.com/symbol/SFLY/earnings\" target=\"_blank\">report earnings</a> tomorrow with analysts expecting $955.05M in revenue.</li><li>SFLY is <font color=\"red\">down 1.8%</font> to $43.73.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429071\" data-linked=\"Goldman restarts Shutterfly at Sell\" data-tweet=\"$SFLY - Goldman restarts Shutterfly at Sell https://seekingalpha.com/news/3429071-goldman-restarts-shutterfly-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3429071-goldman-restarts-shutterfly-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429070\" data-ts=\"1549292809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGNX\" target=\"_blank\">MGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429070-macrogenics-down-8-on-citi-downgrade-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MacroGenics down 8% on Citi downgrade to Sell</a></h4><ul><li>MacroGenics (<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a> <font color=\"red\">-8.3%</font>) slumps on modestly higher volume in early trade following a downgrade to Sell at Citigroup. Analyst Yigal Nochomovitz lacks confidence that its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02492711?lead=macrogenics&amp;phase=2&amp;rank=1\" target=\"_blank\">SOPHIA </a>study evaluating margetuximab + chemo in HER2+ breast cancer patients will demonstrate a statistically valid treatment effect over and above Roche's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color=\"green\">+0.7%</font>) Herceptin (trastuzumab) + chemo. Topline data should be released this quarter.</li><li>Mr. Nochomovitz sees downside risk as high as 30% if the study fails.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429070\" data-linked=\"MacroGenics down 8% on Citi downgrade to Sell\" data-tweet=\"$MGNX $MGNX $RHHBY - MacroGenics down 8% on Citi downgrade to Sell https://seekingalpha.com/news/3429070-macrogenics-down-8-on-citi-downgrade-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3429070-macrogenics-down-8-on-citi-downgrade-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429057\" data-ts=\"1549291925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429057-no-starboard-stake-in-bristol-myers-yet-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">No Starboard stake in Bristol-Myers yet - CNBC</a></h4><ul><li>CNBC's David Faber says that, contrary to a Bloomberg <a href=\"https://www.bloomberg.com/news/articles/2019-02-02/starboard-value-is-said-to-take-stake-in-bristol-myers-squibb\" target=\"_blank\">report</a>, his sources say institutional investor Starboard Value has not spoken with Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.4%</font>) about acquiring a stake.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429057\" data-linked=\"No Starboard stake in Bristol-Myers yet - CNBC\" data-tweet=\"$BMY - No Starboard stake in Bristol-Myers yet - CNBC https://seekingalpha.com/news/3429057-no-starboard-stake-in-bristol-myers-yet-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3429057-no-starboard-stake-in-bristol-myers-yet-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429053\" data-ts=\"1549291645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429053-micron-plans-senior-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron plans senior note offering</a></h4><ul><li>Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) <a href=\"https://seekingalpha.com/pr/17400402-micron-announces-offering-senior-notes\" target=\"_blank\">plans an offering</a> of senior notes followed by a call for redemption of its 3.00% convertible senior notes due 2043.</li><li>Micron will use the net proceeds of the note offering primarily to extinguish obligations for the 2043 convertible notes.</li><li>Micron shares are <font color=\"red\">down 1.9%</font> to $38.84.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429053\" data-linked=\"Micron plans senior note offering\" data-tweet=\"$MU - Micron plans senior note offering https://seekingalpha.com/news/3429053-micron-plans-senior-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3429053-micron-plans-senior-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429048\" data-ts=\"1549291045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429048-jpmorgan-runs-apple-netflix-merger-idea-up-flagpole-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan runs Apple-Netflix merger idea up the flagpole again</a></h4><ul> <li>JPMorgan is out with a <a href=\"https://www.cnbc.com/2019/02/04/jp-morgan-apple-should-buy-netflix.html\" target=\"_blank\">note</a> suggesting that Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+1.2%</font>) acquire Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>).</li> <li>\"We think Netflix is best strategic fit on leading position in engagement level as well as original content, differentiating itself from pure aggregators of content,\" writes JP analyst Samik Chatterjee.</li><li>\"We believe there is value to acquiring the most successful player in this space, which is hard to replicate with a smaller player in this market,\" he adds.</li> <li>A deal for Netflix would cost Apple about $189B at a 20% premium, but is seen leading to long-term streaming and advertising revenue upside.</li> <li>Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) is <font color=\"green\">up 1.45%</font> in early trading, a somewhat muted reaction to the JPMorgan suggestion since it's been kicked around a few times before.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429048\" data-linked=\"JPMorgan runs Apple-Netflix merger idea up the flagpole again\" data-tweet=\"$AAPL $AAPL $NFLX - JPMorgan runs Apple-Netflix merger idea up the flagpole again https://seekingalpha.com/news/3429048-jpmorgan-runs-apple-netflix-merger-idea-up-flagpole-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3429048-jpmorgan-runs-apple-netflix-merger-idea-up-flagpole-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>154&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429034\" data-ts=\"1549290131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429034-vale-halts-production-largest-minas-gerais-mine-following-court-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale halts production at largest Minas Gerais mine following court order</a></h4><ul><li>Vale (NYSE:<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a>) <font color=\"red\">-3.1%</font> pre-market after a Brazilian court reportedly orders the company to <a href=\"https://www.reuters.com/article/vale-disaster-brucutu/brazil-court-tells-vale-to-halt-its-largest-minas-gerais-mine-idUSE6N1XC04D\" target=\"_blank\">suspend production</a> at its Brucutu mine in Minas Gerais state, which has an annual capacity of 30M metric tons of iron ore.</li><li>The move follows the recent rupture of the company's Brumadinho tailings dam that killed at least 100 people.</li><li>Separately, the company that certified the safety of the dam that collapsed has worked as both a consultant and an independent safety evaluator for Vale, raising questions among experts over <a href=\"https://www.wsj.com/articles/inspectors-of-collapsed-brazilian-dam-had-close-ties-to-its-owner-11549054668\" target=\"_blank\">potential conflicts of interest</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429034\" data-linked=\"Vale halts production at largest Minas Gerais mine following court order\" data-tweet=\"$VALE - Vale halts production at largest Minas Gerais mine following court order https://seekingalpha.com/news/3429034-vale-halts-production-largest-minas-gerais-mine-following-court-order?source=tweet\" data-url=\"https://seekingalpha.com/news/3429034-vale-halts-production-largest-minas-gerais-mine-following-court-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429030\" data-ts=\"1549289923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXWL\" target=\"_blank\">MXWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429030-zyne-mxwl-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZYNE, MXWL among premarket gainers</a></h4><ul><li>Maxwell Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MXWL' title='Maxwell Technologies, Inc.'>MXWL</a>) <font color=\"green\">+53%</font> on being <a href=\"https://seekingalpha.com/news/3429004-tesla-acquires-maxwell-technologies\" target=\"_blank\">acquired</a> by Tesla.</li><li>MYnd Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/MYND' title='MYnd Analytics, Inc.'>MYND</a>) <font color=\"green\">+27%</font> on <a href=\"https://seekingalpha.com/pr/17400366-u-s-general-services-administration-awards-federal-supply-schedule-mynd-analytics-provide\" target=\"_blank\">being</a> awarded a five-year federal supply schedule contract as a government supplier, effective January 31, 2019 with the opportunity to renew it for 15 more year.</li><li>The Ultimate Software (NASDAQ:<a href='https://seekingalpha.com/symbol/ULTI' title='Ultimate Software Group, Inc. &#40;The&#41;'>ULTI</a>) <font color=\"green\">+19%</font> on <a href=\"https://seekingalpha.com/news/3428952-ultimate-software-agrees-11b-acquisition\" target=\"_blank\">being</a> by private equity firm Hellman &amp; Friedman for $331.50/share or about $11B.</li><li>Evolus (NASDAQ:<a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a>) <font color=\"green\">+15%</font> as FDA <a href=\"https://seekingalpha.com/news/3428853-fda-oks-evolus-jeuveau-frown-lines\" target=\"_blank\">approves</a> Evolus' Jeuveau for frown lines.</li><li>Aemetis (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a>) <font color=\"green\">+13%</font> as California Energy Commission has issued a notice of proposed award for a <a href=\"https://seekingalpha.com/pr/17399981-aemetis-5-million-grant-announced-low-carbon-fuels-riverbank-biorefinery\" target=\"_blank\">$5M grant</a> to the Aemetis Riverbank cellulosic ethanol biorefinery.</li><li>Zynerba Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a>) <font color=\"green\">+12%</font>.</li><li>Papa John's (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3428985-papa-johns-confirms-starboard-deal\" target=\"_blank\">$200M</a> investment by Starboard Value.</li><li>Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>) <font color=\"green\">+6%</font>.</li><li>Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao'>QTT</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429030\" data-linked=\"ZYNE, MXWL among premarket gainers\" data-tweet=\"$MXWL $MXWL $EMMA - ZYNE, MXWL among premarket gainers https://seekingalpha.com/news/3429030-zyne-mxwl-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3429030-zyne-mxwl-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429026\" data-ts=\"1549289706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429026-yelpplus-2_5-goldman-restarts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp +2.5% as Goldman restarts at Buy</a></h4><ul>   <li>Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>) is <font color=\"green\">up 2.5%</font> premarket after Goldman Sachs reinstated coverage at Buy.</li>    <li>The firm's set its price target to $42, implying 13% upside.</li>    <li>Since its leg down around early November earnings -- shares <font color=\"red\">slid 27%</font> after a <a href=\"https://seekingalpha.com/news/3407798-yelp-plunges-nearly-30-percent-revenue-shortfall\" target=\"_blank\">revenue shortfall</a> -- the stock is <font color=\"green\">up 16.4%</font>. It's <font color=\"green\">up 7.5%</font> in the past month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429026\" data-linked=\"Yelp +2.5% as Goldman restarts at Buy\" data-tweet=\"$YELP - Yelp +2.5% as Goldman restarts at Buy https://seekingalpha.com/news/3429026-yelpplus-2_5-goldman-restarts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3429026-yelpplus-2_5-goldman-restarts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429025\" data-ts=\"1549289689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXWL\" target=\"_blank\">MXWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429025-maxwellplus-52-after-tesla-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxwell +52% after Tesla deal</a></h4><ul> <li>Maxwell Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MXWL' title='Maxwell Technologies, Inc.'>MXWL</a>) soars after announcing its acquisition by Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>). Under terms of the transaction, Maxwell share will be swapped for fractions of Tesla shares.</li> <li>Shares of Maxwell are <font color=\"green\">up 52.2%</font> premarket after coming off a trading halt to $4.66 vs. the deal price of $4.75.</li> <li>Looking ahead to the implications for Tesla, Maxwell's primary focus is on ultracapacitors. The company says the energy storage devices that are characterized by high power density, long operational life, the ability to charge and discharge very rapidly and reliable performance at a wide range of temperatures. Maxwell also thinks its dry electrode technology has the potential to be a revolutionary technology within the battery industry with a substantial market opportunity, particularly for use in electric vehicles.</li> <li>Tesla is <font color=\"red\">down 0.2%</font> in premarket action to $311.75.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3429004-tesla-acquires-maxwell-technologies\" target=\"_blank\">Tesla acquires Maxwell Technologies</a> (Feb. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429025\" data-linked=\"Maxwell +52% after Tesla deal\" data-tweet=\"$MXWL $MXWL $TSLA - Maxwell +52% after Tesla deal https://seekingalpha.com/news/3429025-maxwellplus-52-after-tesla-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3429025-maxwellplus-52-after-tesla-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>180&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429024\" data-ts=\"1549289444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHEK\" target=\"_blank\">CHEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429024-au-and-chek-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AU and CHEK among premarket losers</a></h4><ul><li>Check-Cap (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a>) <font color=\"red\">-25%</font> on <a href=\"https://seekingalpha.com/news/3428983-check-cap-8-percent-premarket-equity-offering\" target=\"_blank\">equity offering</a>.</li><li>AngloGold Ashanti (NYSE:<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a>) <font color=\"red\">-9%</font> despite announcing <a href=\"https://seekingalpha.com/news/3428964-anglogold-ashanti-expects-big-jump-2018-earnings\" target=\"_blank\">leap</a> in 2018 earnings.</li><li>MagneGas Applied Technology Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3429024\" data-linked=\"AU and CHEK among premarket losers\" data-tweet=\"$CHEK $CHEK $AU - AU and CHEK among premarket losers https://seekingalpha.com/news/3429024-au-and-chek-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3429024-au-and-chek-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429022\" data-ts=\"1549289289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRP\" target=\"_blank\">NTRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429022-neurotrope-up-4-premarket-on-nci-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neurotrope up 4% premarket on NCI agreement</a></h4><ul><li>Thinly traded nano cap Neurotrope (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRP' title='Neurotrope, Inc.'>NTRP</a>) is up <font color=\"green\">4%</font> premarket on light volume in reaction to its Cooperative Research and Development <a href=\"https://seekingalpha.com/pr/17400173-neurotrope-announces-cooperative-research-development-agreement-bryostatinminus-1-national\" target=\"_blank\">Agreement </a>with the National Cancer Institute aimed at launching a Phase 1 clinical trial evaluating Bryostatin-1 in children and young adults with CD22-positive leukemia and B-cell lymphoma.</li><li>NCI's Nirali Shah, M.D. will be lead investigator.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429022\" data-linked=\"Neurotrope up 4% premarket on NCI agreement\" data-tweet=\"$NTRP - Neurotrope up 4% premarket on NCI agreement https://seekingalpha.com/news/3429022-neurotrope-up-4-premarket-on-nci-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3429022-neurotrope-up-4-premarket-on-nci-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429009\" data-ts=\"1549288389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ON\" target=\"_blank\">ON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429009-on-semiplus-3-on-q4-eps-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ON Semi +3% on Q4 EPS beat</a></h4><ul><li>ON Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a>)<font color=\"green\"> gains 3.3%</font> premarket on Friday's Q4 report with an EPS beat and in-line revenue with 9% Y/Y revenue growth. Q1 guidance has downside revenue of $1.37B to $1.42B (consensus: $1.45B) and adjusted gross margin of 36.4% to 37.4% (consensus: 37.3%).</li><li>Earnings call is scheduled for 9 AM ET today with a webcast available <a href=\"https://www.onsemi.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17399571-semiconductor-reports-fourth-quarter-2018-annual-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428852-semiconductor-beats-0_06-revenue-line\" target=\"_blank\">ON Semiconductor beats by $0.06,  revenue in-line</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429009\" data-linked=\"ON Semi +3% on Q4 EPS beat\" data-tweet=\"$ON - ON Semi +3% on Q4 EPS beat https://seekingalpha.com/news/3429009-on-semiplus-3-on-q4-eps-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3429009-on-semiplus-3-on-q4-eps-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429007\" data-ts=\"1549288348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429007-intercept-pharma-up-4-premarket-on-bullish-call-from-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intercept Pharma up 4% premarket on bullish call from Raymond James</a></h4><ul><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) is up <font color=\"green\">4%</font> premarket on light volume in apparent reaction to an <a href=\"https://www.streetinsider.com/Analyst+Comments/Raymond+James+Upgrades+Intercept+Pharmaceuticals+%28ICPT%29+to+Strong+Buy%3B+Back+Up+the+Truck+Ahead+of+REGENERATE+Data/15072096.html\" target=\"_blank\">upgrade </a>to Strong Buy at Raymond James citing the likelihood of an FDA nod for obeticholic acid in NASH.</li><li>Topline data from a Phase 3 study should be released this quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3421055-intercept-pharma-4-percent-ahead-data-readout-oca-nash\" target=\"_blank\">Intercept Pharma up 4% ahead of data readout on OCA in NASH</a> (Jan. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429007\" data-linked=\"Intercept Pharma up 4% premarket on bullish call from Raymond James\" data-tweet=\"$ICPT - Intercept Pharma up 4% premarket on bullish call from Raymond James https://seekingalpha.com/news/3429007-intercept-pharma-up-4-premarket-on-bullish-call-from-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3429007-intercept-pharma-up-4-premarket-on-bullish-call-from-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429006\" data-ts=\"1549288116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429006-deutsche-bankminus-1_6-after-wsj-report-on-russian-loan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank -1.6% after WSJ report on Russian loan</a></h4><ul><li>Deutsche Bank (NYSE:<a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a>)<font color=\"red\"> falls 1.6%</font> in premarket trading after the <em>Wall Street Journal</em> reports that <a href=\"https://www.wsj.com/articles/investigators-expected-to-probe-deutsche-efforts-to-shed-loan-to-russian-bank-11549238370?mod=hp_lista_pos3\" target=\"_blank\">Congressional investigators expect</a> the House Financial Services Committee to look at Deutsche Bank's (<a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a>) efforts after the 2016 election to sell a loan it made to a large Russian state-owned bank.</li><li>Deutsche Bank reportedly sought to cut its exposure to Russia in late 2016 and tried to sell a $600M loan it had outstanding to VTB Group.</li><li>The German bank sold $300M of the loan to Russia' Alfa Bank in December 2016, but wasn't able to sell the rest of the loan. VTB paid it back in August 2017, the WSJ reported.</li><li>Separately, MarketWatch reported that Deutsche Bank <a href=\"https://www.marketwatch.com/story/deutsche-bank-turned-down-trump-organization-loan-request-during-2016-campaign-2019-02-02\" target=\"_blank\">turned down a request </a>from the Trump Organization in March 2016 to increase a loan for Trump National Doral, a Florida golf resort, because of concerns about expanding the bank's relationship with then-candidate Donald Trump or his company.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424946-fed-investigating-deutsche-bank-report\" target=\"_blank\">Fed investigating Deutsche Bank - report</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3429006\" data-linked=\"Deutsche Bank -1.6% after WSJ report on Russian loan\" data-tweet=\"$DB - Deutsche Bank -1.6% after WSJ report on Russian loan https://seekingalpha.com/news/3429006-deutsche-bankminus-1_6-after-wsj-report-on-russian-loan?source=tweet\" data-url=\"https://seekingalpha.com/news/3429006-deutsche-bankminus-1_6-after-wsj-report-on-russian-loan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429005\" data-ts=\"1549288018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPRO\" target=\"_blank\">SPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429005-fda-accepts-spero-therapeutics-ind-for-spr994-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts Spero Therapeutics&#39; IND for SPR994; shares up 3% premarket</a></h4><ul> <li>The FDA has <a href=\"https://seekingalpha.com/pr/17399932-spero-therapeutics-announces-fda-acceptance-ind-application-spr994\" target=\"_blank\">accepted</a> Spero Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a>) IND application for SPR994, the first oral carbapenem antibiotic, for the treatment of complicated urinary tract infections (cUTI).  This will enable Spero to initiate U.S. enrollment in its global, single pivotal Phase 3 clinical trial of SPR994 in cUTI.</li>   <li>The primary endpoint of the trial will be the combined clinical and microbiological response at the test of cure with a 10% non-inferiority margin versus IV ertapenem.</li><li>Interim pharmacokinetic data from the trial\u2019s lead-in cohort is anticipated in H2.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3429005\" data-linked=\"FDA accepts Spero Therapeutics&#39; IND for SPR994; shares up 3% premarket\" data-tweet=\"$SPRO - FDA accepts Spero Therapeutics&#39; IND for SPR994; shares up 3% premarket https://seekingalpha.com/news/3429005-fda-accepts-spero-therapeutics-ind-for-spr994-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3429005-fda-accepts-spero-therapeutics-ind-for-spr994-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429001\" data-ts=\"1549287542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTAI\" target=\"_blank\">BTAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429001-bioxcel-up-3-premarket-on-encouraging-iv-dex-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioXcel up 3% premarket on encouraging IV Dex data</a></h4><ul><li>Thinly traded nano cap BioXcel Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BTAI' title='BioXcel Therapeutics'>BTAI</a>) is up <font color=\"green\">3% </font>premarket on light volume in response to positive data from a 15-subject Phase 1b clinical trial evaluating intravenously administered dexmedetomidine (IV Dex) in patients suffering from opioid withdrawal symptoms.</li><li>All 10 participants receiving IV Dex responded to treatment compared to zero for the five who received placebo. The company says IV Dex effectively mitigated the physiological symptoms of opioid withdrawal.</li><li>The sublingual film formulation, BXCL501, can potentially used to treat symptoms of alcohol withdrawal and agitation in schizophrenia, bipolar disorder and dementia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3429001\" data-linked=\"BioXcel up 3% premarket on encouraging IV Dex data\" data-tweet=\"$BTAI - BioXcel up 3% premarket on encouraging IV Dex data https://seekingalpha.com/news/3429001-bioxcel-up-3-premarket-on-encouraging-iv-dex-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3429001-bioxcel-up-3-premarket-on-encouraging-iv-dex-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3429000\" data-ts=\"1549287534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLRX\" target=\"_blank\">BLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3429000-biolinerx-up-36-on-receiving-odd-for-blminus-8040\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLineRx up 36% on receiving ODD for BL-8040</a></h4><ul> <li>The FDA has <a href=\"https://seekingalpha.com/pr/17399925-biolinerx-receives-orphan-drug-designation-fda-lead-therapeutic-candidate-blminus-8040\" target=\"_blank\">granted</a> Orphan Drug Designation &#40;ODD&#41; to BioLineRx's (NASDAQ:<a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a>) lead oncology candidate, BL-8040, for the treatment of pancreatic cancer.</li><li>Among the benefits of Orphan Drug status in the U.S. is a seven-year period of market exclusivity for the indication, if approved.</li><li>Shares are up <font color=\"green\">36%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3429000\" data-linked=\"BioLineRx up 36% on receiving ODD for BL-8040\" data-tweet=\"$BLRX $BLNEF $BLRX - BioLineRx up 36% on receiving ODD for BL-8040 https://seekingalpha.com/news/3429000-biolinerx-up-36-on-receiving-odd-for-blminus-8040?source=tweet\" data-url=\"https://seekingalpha.com/news/3429000-biolinerx-up-36-on-receiving-odd-for-blminus-8040\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428998\" data-ts=\"1549287419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEXEA\" target=\"_blank\">LEXEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428998-expedia-makes-stock-swap-offer-to-liberty-expedia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Expedia makes stock swap offer to Liberty Expedia</a></h4><ul> <li>Liberty Expedia (<a href='https://seekingalpha.com/symbol/LEXEA' title='Liberty Expedia Holdings, Inc.'>LEXEA</a>, <a href='https://seekingalpha.com/symbol/LEXEB' title='Liberty Expedia Holdings, Inc.'>LEXEB</a>) <font color=\"green\">rallies 5%</font> after Expedia (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a>) discloses that it made a stock swap offer.</li> <li>Expedia management and Liberty Expedia Holdings management are currently in talks over the deal.</li> <li>EXPE <font color=\"green\">+1.06%</font> premarket to $123.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428998\" data-linked=\"Expedia makes stock swap offer to Liberty Expedia\" data-tweet=\"$LEXEA $LEXEA $LEXEB - Expedia makes stock swap offer to Liberty Expedia https://seekingalpha.com/news/3428998-expedia-makes-stock-swap-offer-to-liberty-expedia?source=tweet\" data-url=\"https://seekingalpha.com/news/3428998-expedia-makes-stock-swap-offer-to-liberty-expedia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428996\" data-ts=\"1549287170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428996-eyepoint-pharma-up-8-on-u-s-launch-of-yutiq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyePoint Pharma up 8% on U.S. launch of YUTIQ</a></h4><ul><li>EyePoint Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) has commercially <a href=\"https://seekingalpha.com/pr/17399918-eyepoint-pharmaceuticals-announces-u-s-commercial-launch-yutiq-fluocinolone-acetonide\" target=\"_blank\">launched</a> YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg in the U.S. for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.</li><li>The Company has also launched EyePoint Assist, a program to ensure access to YUTIQ for eligible patients in need of financial assistance.</li><li>Shares are up <font color=\"green\">8%</font> premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3428996\" data-linked=\"EyePoint Pharma up 8% on U.S. launch of YUTIQ\" data-tweet=\"$EYPT - EyePoint Pharma up 8% on U.S. launch of YUTIQ https://seekingalpha.com/news/3428996-eyepoint-pharma-up-8-on-u-s-launch-of-yutiq?source=tweet\" data-url=\"https://seekingalpha.com/news/3428996-eyepoint-pharma-up-8-on-u-s-launch-of-yutiq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428992\" data-ts=\"1549287018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETH\" target=\"_blank\">ETH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428992-ethan-allenminus-2-after-raynond-james-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ethan Allen -2% after Raynond James downgrade</a></h4><ul> <li>Shares of Ethan Allen (NYSE:<a href='https://seekingalpha.com/symbol/ETH' title='Ethan Allen Interiors Inc.'>ETH</a>) are <font color=\"red\">down 2.33%</font> after Raymond James lowers the retailer to a Market Perform rating from Outperform.</li> <li>The downgrade follows Ethan Allen's FQ2 earnings report last week that showed a drop in sales and operating margin.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3427033-ethan-allen-falls-multi-year-low\" target=\"_blank\">Ethan Allen falls to multi-year low</a> (Jan. 29)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3428992\" data-linked=\"Ethan Allen -2% after Raynond James downgrade\" data-tweet=\"$ETH - Ethan Allen -2% after Raynond James downgrade https://seekingalpha.com/news/3428992-ethan-allenminus-2-after-raynond-james-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3428992-ethan-allenminus-2-after-raynond-james-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428989\" data-ts=\"1549286750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYY\" target=\"_blank\">SYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428989-syscoplus-2-after-fq2-margin-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sysco +2% after FQ2 margin gains</a></h4><ul> <li>Sysco (NYSE:<a href='https://seekingalpha.com/symbol/SYY' title='Sysco Corporation'>SYY</a>) reports gross profit increased 2.7% in <a href=\"https://seekingalpha.com/pr/17400062-sysco-reports-second-quarter-fiscal-2019-results\" target=\"_blank\">FQ2</a> to $2.8B off a 2.5% jump in sales. Gross margin as a percentage of sales increased 4 bps to 18.77%.</li><li>Case growth was 2.9% for the U.S. broadline business and 3.3% for the local business.</li>  <li>Operating income was up 4.8% Y/Y to $603M during the quarter. Operating margin as a percentage of sales increased 9 bps to 4.09%.</li> <li>Sysco says cash flow from operations for the first 26 weeks of the fiscal year was $918M vs. $933M a year ago.</li> <li>Shares of Sysco are <font color=\"green\">up 2.25%</font> in premarket trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428977-sysco-beats-0_02-revenue-line\" target=\"_blank\">Sysco beats by $0.02,  revenue in-line</a> (Feb. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428989\" data-linked=\"Sysco +2% after FQ2 margin gains\" data-tweet=\"$SYY - Sysco +2% after FQ2 margin gains https://seekingalpha.com/news/3428989-syscoplus-2-after-fq2-margin-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3428989-syscoplus-2-after-fq2-margin-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428988\" data-ts=\"1549286584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCI\" target=\"_blank\">GCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428988-gannett-rejects-mng-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gannett rejects MNG bid</a></h4><ul><li>The proposal had been for $12 per share in cash. Gannett (NYSE:<a href='https://seekingalpha.com/symbol/GCI' title='Gannett Co., Inc.'>GCI</a>) is <font color=\"red\">lower by 1.5%</font> premarket to $11.05.</li><li>The <a href=\"https://seekingalpha.com/pr/17400056-gannett-board-directors-unanimously-rejects-unsolicited-proposal-mng-enterprises-inc\" target=\"_blank\">board feels the</a> MNG bid isn't credible - noting little engagement from the group, and no details about how the purchase would be financed.</li><li>Next up for the board to deal with may be Alden Global Capital, <a href=\"https://seekingalpha.com/news/3424260-report-alden-readies-opposing-slate-gannett-resists-bid\" target=\"_blank\">which has promised to</a> keep the pressure up on Gannett should it resist the MNG bid.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428988\" data-linked=\"Gannett rejects MNG bid\" data-tweet=\"$GCI - Gannett rejects MNG bid https://seekingalpha.com/news/3428988-gannett-rejects-mng-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3428988-gannett-rejects-mng-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428987\" data-ts=\"1549286492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428987-eyepoint-up-8-premarket-on-u-s-launch-of-yutiq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyePoint up 8% premarket on U.S. launch of Yutiq</a></h4><ul><li>EyePoint Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) is up <font color=\"green\">8%</font> premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17399918-eyepoint-pharmaceuticals-announces-u-s-commercial-launch-yutiq-fluocinolone-acetonide\" target=\"_blank\">U.S. commercial launch</a> of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.</li><li>The FDA approved the product about four months ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428987\" data-linked=\"EyePoint up 8% premarket on U.S. launch of Yutiq\" data-tweet=\"$EYPT - EyePoint up 8% premarket on U.S. launch of Yutiq https://seekingalpha.com/news/3428987-eyepoint-up-8-premarket-on-u-s-launch-of-yutiq?source=tweet\" data-url=\"https://seekingalpha.com/news/3428987-eyepoint-up-8-premarket-on-u-s-launch-of-yutiq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428983\" data-ts=\"1549285950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHEK\" target=\"_blank\">CHEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428983-check-cap-down-8-premarket-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Check-Cap down 8% premarket on equity offering</a></h4><ul><li>Thinly traded nano cap Check-Cap (NASDAQ:<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a>) is down <font color=\"red\">8% </font>premarket on higher-than-normal volume in response to its <a href=\"https://seekingalpha.com/pr/17399989-check-cap-ltd-announces-7_5-million-registered-direct-offering\" target=\"_blank\">direct offering</a> of ~2.9M units at $2.58/unit to institutional investors.</li><li>Each unit consists of one ordinary share and one warrant to purchase 1/2 of an ordinary share at $2.58.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428983\" data-linked=\"Check-Cap down 8% premarket on equity offering\" data-tweet=\"$CHEK - Check-Cap down 8% premarket on equity offering https://seekingalpha.com/news/3428983-check-cap-down-8-premarket-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3428983-check-cap-down-8-premarket-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428982\" data-ts=\"1549285858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THO\" target=\"_blank\">THO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428982-thor-industriesminus-2-after-bmo-capital-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thor Industries -2% after BMO Capital cut</a></h4><ul> <li>Thor Industries (NYSE:<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a>) skids in early trading after BMO Capital downgrades the RV manufacturer to a Market Perform rating after having it lined up at Outperform.</li> <li>The firm expects some growing pains for Thor after its acquisition of Erwin Hymer.</li> <li>BMO's price target on Thor goes to $62 from $78.</li> <li>Shares of Thor are <font color=\"red\">down 1.94%</font> in premarket trading to $62.65. Thor is down 53% over the last 52 weeks vs. -37% for Winnebago and -27% for LCI Industries.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428982\" data-linked=\"Thor Industries -2% after BMO Capital cut\" data-tweet=\"$THO - Thor Industries -2% after BMO Capital cut https://seekingalpha.com/news/3428982-thor-industriesminus-2-after-bmo-capital-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3428982-thor-industriesminus-2-after-bmo-capital-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428977\" data-ts=\"1549285469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYY\" target=\"_blank\">SYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428977-sysco-beats-0_02-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sysco beats by $0.02,  revenue in-line</a></h4><ul><li>Sysco (NYSE:<a href='https://seekingalpha.com/symbol/SYY' title='Sysco Corporation'>SYY</a>): Q2 Non-GAAP EPS of $0.75 <span style=\"color:green\">beats by $0.02</span>; GAAP EPS of $0.51 <span style=\"color:red\">misses by $0.19</span>.</li><li>Revenue of $14.77B (+2.5% Y/Y) in-line.</li><li>Shares <font color=\"green\">+3.11%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17400062-sysco-reports-second-quarter-fiscal-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428977\" data-linked=\"Sysco beats by $0.02,  revenue in-line\" data-tweet=\"$SYY - Sysco beats by $0.02, revenue in-line https://seekingalpha.com/news/3428977-sysco-beats-0_02-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3428977-sysco-beats-0_02-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428974\" data-ts=\"1549285271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428974-catalyst-pharma-in-sen-sanders-crosshairs-over-firdapse-pricing-shares-down-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma in Sen. Sanders&#39; crosshairs over Firdapse pricing; shares down 4% premarket</a></h4><ul><li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) is down <font color=\"red\">4%</font> premarket on light volume on the heels of the <a href=\"https://www.reuters.com/article/us-usa-healthcare-catalyst-idUSKCN1PT0ZJ?utm_campaign=trueAnthem:+Trending+Content&amp;utm_content=5c5826f004d3013819321abd&amp;utm_medium=trueAnthem&amp;utm_source=twitter\" target=\"_blank\">news </a>that Sen. Bernie Sanders (I-VT) has sent it a letter asking why Firdapse (amifampridine), approved by the FDA about two months ago for the treatment of a rare autoimmune disorder called Lambert-Eaton myasthenic syndrome, costs $375K when patients were previously getting it for free.</li><li>\u201cCatalyst\u2019s decision to set the annual list price at $375,000 is not only a blatant fleecing of American taxpayers, but is also an immoral exploitation of patients who need this medication,\u201d the letter says.</li><li>Patients has been receiving the drug at no charge from a New Jersey drugmaker under an FDA compassionate use program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428974\" data-linked=\"Catalyst Pharma in Sen. Sanders&#39; crosshairs over Firdapse pricing; shares down 4% premarket\" data-tweet=\"$CPRX - Catalyst Pharma in Sen. Sanders&#39; crosshairs over Firdapse pricing; shares down 4% premarket https://seekingalpha.com/news/3428974-catalyst-pharma-in-sen-sanders-crosshairs-over-firdapse-pricing-shares-down-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3428974-catalyst-pharma-in-sen-sanders-crosshairs-over-firdapse-pricing-shares-down-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428964\" data-ts=\"1549284544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428964-anglogold-ashanti-expects-big-jump-in-2018-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AngloGold Ashanti expects big jump in 2018 earnings</a></h4><ul><li>AngloGold Ashanti (NYSE:<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a>) says <a href=\"https://www.miningmx.com/trending/35806-anglogold-ashanti-to-post-healthy-leap-in-earnings-as-sa-costs-fall-away/\" target=\"_blank\">FY 2018 adjusted earnings rose more than 7x</a> to $207M-$224M from $27M in the previous year, with headline EPS of $0.50-$0.54 vs. $0.06 in FY 2017.</li><li>AU cites lower amortization levels for South Africa with the closure of TauTona  in 2017 and the sale of the Moab Khotsong and Kopanang operations early  in 2018, as well as a $95M jump in income from its Kibali operation in the Democratic Republic of Congo, as reasons for the improvement.</li><li>However, AU <font color=\"red\">-7.5%</font> pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428964\" data-linked=\"AngloGold Ashanti expects big jump in 2018 earnings\" data-tweet=\"$AU - AngloGold Ashanti expects big jump in 2018 earnings https://seekingalpha.com/news/3428964-anglogold-ashanti-expects-big-jump-in-2018-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3428964-anglogold-ashanti-expects-big-jump-in-2018-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}